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Abstract
In HIV/AIDS studies, viral load (the number of copies of HIV-1 RNA) and CD4 cell counts
are important biomarkers of the severity of viral infection, disease progression, and treat-
ment evaluation. Recently, joint models, which have the capability on the bias reduction
and estimates’ efficiency improvement, have been developed to assess the longitudinal pro-
cess, survival process, and the relationship between them simultaneously. However, the
majority of the joint models are based on mean regression, which concentrates only on the
mean effect of outcome variable conditional on certain covariates. In fact, in HIV/AIDS
research, the mean effect may not always be of interest. Additionally, if obvious outliers or
heavy tails exist, mean regression model may lead to non-robust results. Moreover, due to
some data features, like left-censoring caused by the limit of detection (LOD), covariates
with measurement errors and skewness, analysis of such complicated longitudinal and sur-
vival data still poses many challenges. Ignoring these data features may result in biased
inference.
Compared to the mean regression model, quantile regression (QR) model belongs to a
robust model family, which can give a full scan of covariate effect at different quantiles of
the response, and may be more robust to extreme values. Also, QR is more flexible, since
the distribution of the outcome does not need to be strictly specified as certain parametric
assumptions. These advantages make QR be receiving increasing attention in diverse areas.
To the best of our knowledge, few study focuses on the QR-based joint models and applies
to longitudinal-survival data with multiple features.
Thus, in this dissertation research, we firstly developed three QR-based joint models via
Bayesian inferential approach, including: (i) QR-based nonlinear mixed-effects joint models
for longitudinal-survival data with multiple features; (ii) QR-based partially linear mixed-
effects joint models for longitudinal data with multiple features; (iii) QR-based partially
linear mixed-effects joint models for longitudinal-survival data with multiple features. The
proposed joint models are applied to analyze the Multicenter AIDS Cohort Study (MACS)
vi
data. Simulation studies are also implemented to assess the performance of the proposed
methods under different scenarios. Although this is a biostatistical methodology study,
some interesting clinical findings are also discovered.
vii
Chapter 1 Introduction and literature review
1.1 Background of HIV/AIDS research
Human immunodeficiency virus (HIV) is a virus spread through certain body fluids, attacks
the human bodys immune system, and finally may lead to acquired immunodeficiency syn-
drome (AIDS). The typical progression of HIV infection includes three stages: (i) acute HIV
infection; (ii) clinical latency or HIV inactivity; (iii) AIDS. Although treatment, especially
the antiretroviral therapy (ART), can slow or prevent progression from one stage to the
next, it cannot completely eliminate HIV from the infected human body. In other words,
once the human is infected by HIV, the virus will stay in the body for life. Thus, HIV
infection continues to be a major global public health crisis.
During 2010 to 2014, the number of diagnoses of HIV infection in the United States
decreased (see Figure 1(a)) [1]. In 2014, an estimated 1,100,000 people were living with
HIV, and 15% of them did not know they were infected. Interestingly, the numbers of
diagnosed HIV infection varied among different subgroups. For example, in 2014, young
people aged from 20 to 29 (Figure 1(b)), African American (Figure 1(c)), and those with
male-to-male sexual contact (Figure 1(d)) are the most affected. Totally, there were an
estimated 37,600 new HIV infections in 2014, and 26,200 of these new HIV infections were
gay, bisexual, and other men who have sex with men. Among them, young African American
gay and bisexual men, are most affected subgroup. Similar to the prevalence, the number
of deaths of persons with diagnosed HIV infection decreased from 2010 to 2014 [1]. In 2014,
6,721 people died from HIV and AIDS, and it was the 8th leading cause of death for people
aged from 25 to 34 and the 9th for those aged from 35 to 44. HIV remains a major public
health problem, and significant cause of death for some populations in the United States.
In HIV/AIDS studies, viral load (the number of copies of HIV-1 RNA per milliliter
plasma) and CD4 cell counts are important biomarkers of the severity of viral infection,
1
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disease progression, and treatment evaluation [2]. In the first few weeks of infection, viral
load, which describes the amount of HIV in a patient’s blood, is usually extremely high,
indicating those are more infectious and at greater risk. If the patient does not choose to
take HIV treatment, the viral load will be monitored at regular clinic visits to provide clues
of the HIV infection progression. If taking the treatment, viral load will start to fall. It
is a good sign that the viral load three or six weeks after starting HIV treatment becomes
undetectable. Even after the viral load is undetectable or the treatment is effective, the
patient should make viral load be monitored every six months or one year [3]. Moreover,
due to the low sensitivity of current standard assays, the measurement of viral load in an
HIV positive individual is only accurate above a particular limit of detection (LOD). For
example, in some HIV/AIDS studies, values of viral load below the LOD (40 copies/ml)
cannot be reliably quantified. Importantly, undetectable viral load does not mean that HIV
has disappeared completely from the body. HIV may still exist in the body, but too low to
be detected. The goal of HIV treatment is to lower the viral load below the LOD.
Compared to viral load, CD4 cell count can provide more information to help monitor
the health of a patient’s immune system. CD4 cells, also named as T-cells, are a type
of white blood cell that play an important role in human immune system. They send
certain signals to activate human body’s immune response when they detect “intruders”,
such as HIV. Due to certain receptors on CD4 cells, HIV will attack human CD4 cells once
get infected. That will lead to great decrease of the number of CD4 cells, weakening the
immune system. For a normal person, CD4 count keeps in the range of 500 to 1,600 cells per
cubic millimeter. In clinical, if the CD4 count is below 200 cells per cubic millimeter, the
patient may be diagnosed with the third stage: AIDS [4]. At this stage, the immune system
is too weak to battle with the disease. Thus, physicians can use the CD4 cell counts as an
indicator to track the patients’ health status, and to decide when to start the treatment.
After starting the therapy, CD4 counts is also measured to check the effectiveness of the
treatment regimen.
In HIV/AIDS studies, viral load and CD4 cell counts are repeatedly measured on average
every three to six months (more often at the beginning, and less frequently after the ART
works well). The trends of the viral load and CD4 cell counts over time, whether rising
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or falling, are more important than an individual test result. The more quickly viral load
increases, the faster CD4 cell counts drop, then the faster symptoms develop, and the greater
risk of becoming AIDS and even death the patient has. Therefore, accurately modeling HIV
activity and CD4 cell counts is critically important for HIV infected patients, physicians,
and other HIV care providers.
1.2 Literature review of quantile regression
In statistical modeling, regression has been developed to quantify the relationship between
dependent variable (outcome) and independent variables (covariates) for over 200 years. The
classic regression has been one of the most widely used statistical methods to capture the
effects at the mean. However, such average effects are not always of interest in many areas.
For example, currently, “precision health/medicine” [5] have been widely adopted in health
related areas. A lot of researchers, clinicians, and policymakers have showed increasing
attention on group differences across the entire population rather than that solely on the
average. Mean regression can not satisfy with all of these needs or requirements.
Developed by Koenker and Bassett in 1978 [6], quantile regression (QR) complements
and improves the traditional mean regression models. QR quantifies the heterogeneous
effects of covariates through conditional quantiles of the outcome variable, and provides a
comprehensive scan of the whole distribution of the outcome. In addition, it is well known
that when asymmetries and heavy tails exist, the sample median (the 50th percentile), one
of the best-known example of quantiles, provides a better summary of centrality than the
mean. As a consequence, compared to the standard mean regression models, QR is more
robust to outliers and more flexible, because the distribution of the outcome does not need
to be strictly specified as certain parametric assumptions. Although mean regression-based
methods still dominate the statistical modeling field, QR can be viewed as a critical exten-
sion and complement when assumptions are violated. Thus, QR has attracted considerable
research interest in decades, and has been widely applied to independent data, time-to-event
data, and longitudinal data [7]. The different QR approaches can be roughly classified into
two groups: (i) minimization of weighted absolute deviations, which is a typical inferential
method used in QR; and (ii) the maximization of a Laplace likelihood.
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The former is based on Koenker and Bassett’s work [6], which estimated the conditional
median and a full range of other quantile functions by minimizing asymmetrically weighted
absolute residuals. Generally, let xi and yi denote the covariate vector and the outcome of
interest for subject i (i = 1, . . . , n). In particular, yi denotes independent scalar observations
of a continuous random variable with general cumulative distribution function (cdf) Fyi(·).
The QR model with τth quantile for yi given xi takes the following form:
Qyi(τ |xi) = g(xi,β), (1.1)
where Qyi(·) ≡ F−1yi (·) is the inverse of the cdf of yi given xi estimated at τ with the range
from 0 to 1. The vector of regression coefficients β is estimated by minimizing
n∑
i=1
ρτ (yi − g(xi,β)) , (1.2)
where ρτ (·) is the check function with the definition of ρτ (u) = u(τ − I(u < 0)), and I(·)
is an indictor. A full discussion of this class of methods could be found from many related
publications [6, 8, 9]. Traditional QR makes minimal assumptions on the form of the error
term, which is flexible, but inference for these models is challenging, particularly when the
data features are complicated.
The latter is built on the asymmetric Laplace distribution (ALD) [10–12], and other
parametric distributions, like an infinite mixture of Gaussian densities [13]. Some literature
has discussed the ALD, which is close to the check function of QR [8,10,12,14]. If a random
variable Y follows ALD, then its probability density function (pdf) with three parameters,
including µ, σ and τ , is given by
f(y|µ, σ, τ) = τ(1− τ)
σ
exp
{
−ρτ
(
y − µ
σ
)}
, (1.3)
where 0 < τ < 1 is the parameter of skewness, σ > 0 is the parameter of scale, −∞ < µ <∞
is the parameter of location, and ρτ (u) = u(τ−I(u < 0)) represents the check function. We
call the above distribution ALD(µ, σ, τ), and the range of random variable y is (−∞, ∞).
Briefly, if Y ∼ ALD(µ, σ, τ), then Pr(y ≤ µ) = τ and Pr(y > µ) = 1−τ . This important
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feature shows that µ and τ in ALD satisfy µ to be the τth quantile of the distribution.
However, since the ALD is not smooth, it is difficult to maximize the likelihood function
of it. Fortunately, as described in these studies [15, 16], the ALD has various mixture
representations. A hierarchical mixture of an exponential and a normal distribution is
utilized to develop algorithms for the QR models [15,16]. For Y ∼ ALD(µ, σ, τ), Y can be
decomposed as the following mixture representation:
Y = µ+ ϑ1X1 +
√
ϑ2σX1X2, (1.4)
where X1 ∼ Exp( 1σ ) with mean σ and X2 ∼ N(0, 1), X1 and X2 are mutually independent,
ϑ1 = (1− 2τ)/[τ(1− τ)] and ϑ2 = 2/[τ(1− τ)]. This representation can help us transform
the ALD to a smooth conditional normal distribution, and widely apply to different studies.
Thus, a two-level hierarchical representation of (1.4) is given by
Y |X2 ∼ N(µ+ ϑ1X1, ϑ2σX1), X1 ∼ Exp( 1
σ
). (1.5)
These important features of ALD have been generally adopted for likelihood based
quantile inference, as well as the Bayesian inference. See Yu and Zhang’s work [12] for
further properties and generalizations of this distribution as well as its close relationship with
QR. By using this property, for independent data, a large number of QR-based regression
models and many related analysis methods have been investigated in the literature. For
instance, a likelihood-based goodness-of-fit test has been proposed for QR [8]; Bayesian
QR [10] , and the Bayesian estimation procedure for the Tobit QR model with censored
data [16,17], have also been developed.
Importantly, these two types of inferential methods for QR-based models are not mutu-
ally exclusive. The relationship between the ALD and QR’s check function can be utilized
to re-formulate the QR method under the likelihood-based framework. If consider σ as a
nuisance parameter, it is easy to show that the minimization of equation (1.2) in the former
method with respect to the parameter β is exactly equivalent to the maximization of an
ALD-based likelihood function in the latter.
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It has been demonstrated that QR is widely used to analyze independent data in many
important application areas. Due to the importance of modeling extreme values accurately,
the foreign direct investment (FDI), finance and economics are the most important area
where QR is utilized [7]. In addition, QR is becoming more popular in clinical, biomedical,
and other health related research. For example, Austin et al. [18] examined the varying
gender differences in the delivery of thrombolysis in patients with an acute myocardial
infarction by QR. Briollais and Durrieu [19] provided a review of recent applications of
QR to the area of genetics. Azagba and Sharaf [20] identified that increasing the intake of
fruits and vegetables may be an effective dietary strategy to control weight and mitigate
the risk of obesity, which is more effective at the higher quantiles of the body mass index
(BMI) distribution. More applications of QR to independent data could be found in various
fields, such as public health [21, 22], bioinformatics [23], healthcare [24, 25], environmental
science [26], and ecology [27,28].
Mimic to independent data, QR has also been extended and applied to longitudinal
data. Longitudinal QR has the capability, at both of the population and individual level, to
identify heterogeneous covariates effects, and describe differences in longitudinal changes at
different quantiles of the outcome. Longitudinal QR models, specifically QR-based mixed-
effects models have been proposed via different statistical approaches, which could also
be classified into two categories: distribution-free and likelihood-based. In details, for
example, Jung [29] firstly developed a quasi-likelihood method for median regression con-
sidering correlations between repeated measures for dependent data. He et al. [30] pro-
posed a median regression based linear mixed-effects (LME) model for longitudinal data.
Koenker [31] generalized his previous work on QR to longitudinal data via penalized least
squares method. Other methods or algorithms used to QR includes Barrodale-Roberts
algorithm [32], Expectation-Maximization (EM) algorithm [33], Monte Carlo Expectation-
Maximization (MCEM) algorithm [14, 34, 35], and Bayesian approach by Markov chain
Monte Carlo (MCMC) procedure [36–44]. Longitudinal QR has been rapidly expanded
in many areas, including investment and finance [45, 46], economics [47], environmental
science [48,49], geography [50], public health [51,52] and biomedical research [53–56].
Data collected in many longitudinal studies record much information, not only repeated
7
measures, but also time-to-event information. To model this kind of longitudinal-survival
data, joint models have become an active area of statistics, because of its capability on
the bias reduction and improvement of estimates’ efficiency. More recently, QR has been
extended to more complicated joint models in AIDS research. Farcomeni and Viviani [35] de-
veloped QR-based longitudinal-survival joint models in the presence of informative dropout.
Huang et al. proposed QR-based mixed-effects joint models by considering many longitudi-
nal data features simultaneously, including covariate measurement errors [39, 40, 43], miss-
ing [40,41], non-normality [40–42], left-censoring [39,42], and time-to-event outcomes [41].
1.3 Multivariate skew distributions
Different versions of the multivariate skew-t (ST) distributions have been proposed and
used in the literature [57–62]. A new class of distributions by introducing skewness in
multivariate elliptically distributions were developed in the literature [57, 61]. By using
conditioning and transformation, this new class contains many standard families including
the multivariate SN and ST distributions as special cases. A k-dimensional random vector
Y follows a k-variate skew-elliptical (SE) distribution if its pdf is given by
f(y|µ,Σ,∆;m(k)ν ) = 2kf(y|µ,A;m(k)ν )P (V > 0), (1.6)
where A = Σ + ∆2, µ is a parameter vector of location, Σ is a k × k covariance matrix
with positive elements, ∆ is a k × k diagonal skewness matrix ∆ = diag(δ1, δ2, . . . , δk),
δ = (δ1, δ2, . . . , δk)
T is the parameter vector of skewness; V follows the elliptical distribu-
tion El
(
∆A−1(y − µ), Ik −∆A−1∆;m(k)ν
)
with the density generator function m
(k)
ν (u) =
uk/2−1mν(u)∫∞
0 u
k/2−1mν(u)du
, mν(u) is a function such that
∫∞
0 u
k/2−1mν(u)du exists. The function
mν(u) provides the kernel of the original elliptical density and may depend on the param-
eter ν. This SE distribution is denoted by SE(µ,Σ,∆;m
(k)
ν ). Two examples of mν(u),
leading to important special cases used throughout the paper, are mν(u) = exp(−u/2) and
mν(u) = (1 + u/ν)
−(ν+k)/2, where ν > 0. These two expressions lead to the multivariate
SN and ST distributions, respectively. In the latter case, ν corresponds to the degrees of
freedom parameter.
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Since the SN distribution is a special case of the ST distribution when degrees of freedom
are large, for completeness, this Appendix briefly summarizes the multivariate SN and
ST distributions that will be used in defining the ST and SN models considered in this
paper. Assume a k-dimensional random vector Y follows a k variate SN or ST distribution
with location vector µ, k × k positive (diagonal) covariance matrix Σ and k × k diagonal
skewness matrix ∆ = diag(δ1, δ2, . . . , δk) or the degrees of freedom ν. In what follows, we
briefly discuss the multivariate SN and ST distributions introduced by Sahu et al. [61] to
be suitable for a Bayesian inference since they are built using the conditional method. For
detailed discussion on properties of SN and ST distributions, see the Reference [61].
1.3.1 Skew-t distribution
A k-dimensional random vector Y follows a k-variate ST distribution if its probability
density function (pdf) is given by
f(y|µ,Σ,∆, ν) = 2ktk,ν(y|µ,A)P (V > 0), (1.7)
where we denote the k-variate t distribution with parameters µ, A and degrees of freedom
ν by tk,ν(µ,A) and the corresponding pdf by tk,ν(y|µ,A) henceforth, V follows the t distri-
bution tk,ν+k(∆A
−1(y−µ), Ik−∆A−1∆). We denote this distribution by STk,ν(µ,Σ,∆).
In particular, when Σ = σ2Ik and ∆ = δIk, equation (1.7) simplifies to
f(y|µ, σ2, δ, ν) = 2k(σ2 + δ2)−k/2 Γ((ν+k)/2)
Γ(ν/2)(νpi)k/2
{
1 +
(y−µ)T (y−µ)
ν(σ2+δ2)
}−(ν+k)/2
×Tk,ν+k
[{
ν+(σ2+δ2)−1(y−µ)T (y−µ)
ν+k
}−1/2 δ(y−µ)
σ
√
σ2+δ2
]
,
(1.8)
where Tk,ν+k(·) denotes the cumulative distribution function (cdf) of tk,ν+k(0, Ik). However,
unlike the SN distribution below, the ST density can not be written as the product of
univariate ST densities. Here Y is dependent but uncorrelated. It is noted that when
δ = 0, the ST distribution reduces to usual the t-distribution. It can be shown that the
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mean and covariance matrix of the ST distribution STk,ν(µ, σ
2Ik,∆) are given by
E(Y ) = µ+ (ν/pi)1/2 Γ((ν−1)/2)Γ(ν/2) δ,
cov(Y ) =
[
σ2Ik + ∆
2
]
ν
ν−2 − νpi
[
Γ{(ν−1)/2}
Γ(ν/2)
]2
∆2.
(1.9)
Following the studies [60,63], if Y follows STk,ν(µ,Σ,∆), it can be represented by
Y = µ+ u−1/2X (1.10)
where u follows a Gamma distribution Γ(ν/2, ν/2), which is independent of X, and X
follows a k-dimensional skew-normal (SN) distribution, denoted by SNk(0,Σ,∆). It follows
from (1.10) that Y |u ∼ SNk(µ, u−1Σ, u−1/2∆). Following the results [57, 58, 61], the SN
distribution of Y , conditional on u, has a convenient stochastic representation as
Y = µ+ u−1/2∆|X0|+ u−1/2Σ1/2X1, (1.11)
where X0 and X1 are two independent Nk(0, Ik) random vectors. Note that the expression
(1.11) provides a convenient device for random number generation and for implementation
purpose. Let w = u−1/2|X0|; then w, conditional on u, follows a k-dimensional normal
distribution Nk(0, u
−1Ik) truncated in the space w > 0 (i.e., the half-normal distribution).
Thus, a hierarchical representation of (1.11) is given by
Y |w, u ∼ Nk(µ+ ∆w, u−1Σ), w|u ∼ Nk(0, u−1Ik)I(w > 0), u ∼ Γ(ν/2, ν/2), (1.12)
Note that the ST distribution STk,ν(µ,Σ,∆) presented in (1.12) can be reduced to
the following three special cases: (i) as ν → ∞ and u → 1 with probability 1 (i.e., the
last distributional specification is omitted), then the hierarchical expression (1.12) becomes
an SN distribution SNk(µ,Σ,∆); (ii) as ∆ = 0, then the hierarchical expression (1.12)
is a standard multivariate t-distribution; (iii) as ν → ∞, u → 1 with probability 1 and
∆ = 0, then the hierarchical expression (1.12) reverts to a standard multivariate normal
distribution.
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1.3.2 Skew-normal distribution
We briefly discuss a multivariate SN distribution introduced by Sahu et al. [61] in this
section. A k-dimensional random vector Y follows a k-variate SN distribution, if its pdf is
given by
f(y|µ,Σ,∆) = 2k|A|−1/2φk{A−1/2(y − µ)}P (V > 0), (1.13)
where V ∼ Nk{∆A−1(y−µ), Ik−∆A−1∆}, and φk(·) is the pdf of Nk(0, Ik). We denote
the above distribution by SNk(µ,Σ,∆). An appealing feature of equation (1.13) is that it
gives independent marginal when Σ = diag(σ21, σ
2
2, . . . , σ
2
k). The pdf (1.13) thus simplifies
to
f(y|µ,Σ,∆) = ∏ki=1 [ 2√σ2i+δ2i φ
{
yi−µi√
σ2i+δ
2
i
}
Φ
{
δi
σi
yi−µi√
σ2i+δ
2
i
}]
, (1.14)
where φ(·) and Φ(·) are the pdf and cdf of the standard normal distribution, respectively.
It can be easily shown that the mean and covariance matrix are given by E(Y ) =
µ+
√
2/piδ, cov(Y ) = Σ + (1− 2/pi)∆2. It is noted that when δ = 0, the SN distribution
reduces to usual normal distribution. In addition, the SN distribution is a special case of the
ST distribution. That is, the ST distribution reduces to the SN distribution when degrees
of freedom are large. In order to have a zero mean vector, we should assume the location
parameter µ = −√2/piδ.
According to the literature [58,61], if Y follows SNk(µ,Σ,∆), it can be expressed by a
convenient stochastic representation as follows.
Y = µ+ ∆|X0|+ Σ1/2X1, (1.15)
where X0 and X1 are two independent Nk(0, Ik) random vectors. Let w = |X0|; then,
w follows a k-dimensional standard normal distribution Nk(0, Ik) truncated in the space
w > 0. Thus, a two-level hierarchical representation of (1.15) is given by
Y |w ∼ Nk(µ+ ∆w,Σ), w ∼ Nk(0, Ik)I(w > 0). (1.16)
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1.4 Specific aims
In HIV/AIDS studies, the time trends of repeatedly measured viral load and CD4 cell
counts may be heterogeneous at different quantiles, and also be predictive of the risk of a
terminal event. Viral load changes can be very large, even quantified using ‘log scale’, it is
still skewed distributed. To accurately model such complicated longitudinal-survival data,
rather than the majority of existing studies using the traditional mean regression-based
joint models, this research focuses on QR-based mixed-effects joint models, and attempts
to address the following three specific questions:
• First, linear function is the most commonly used for the QR-based mixed-effects joint
models. However, in real research, the linearity assumption is too idea to be true.
A QR-based nonlinear mixed-effects joint models for longitudinal-survival data and
related inference method are demanded, in order to better understand the nonlinear
longitudinal dynamics of the viral load at different quantiles and their associations
with the survival time.
• Second, the parametric regression methods have suffered from the inflexibility and
possible misspecification in modeling complicated longitudinal data. Besides, the
nonparametric methods may bring the problem known as “curse of dimensionality”.
With the consideration, a partially linear mixed-effects model (PLMM), which serves
as an intermediate class of models, enjoys the good robustness from its nonparametric
part and good precision from the parametric part. PLMM for longitudinal data is pre-
ferred to be applied under the QR framework, which may comprehensively investigate
the distinct CD4 effects and the longitudinal trends of viral load.
• Third, continuing to the second research question, the heterogeneous longitudinal
dynamics of viral load and CD4 cell counts, as well as other important risk factors,
may be predictive of the risk of death. An extension of the PLMM, which models
the longitudinal data only, a QR-based PLMM joint models for longitudinal-survival
data are desired to fully study the associations.
Therefore, this dissertation research is organized as follow:
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• Aim 1. In Chapter 3, we present a QR-based nonlinear mixed-effects joint models
for longitudinal-survival data with multiple data features, and corresponding Bayesian
inference method. A real AIDS study data analysis and simulation studies are con-
ducted.
• Aim 2. In Chapter 4, we propose a QR-based partially linear mixed-effects joint
models for longitudinal data with multiple features, and apply to a real AIDS study.
Simulation studies are also implemented.
• Aim 3. In Chapter 5, we develop a QR-based partially linear mixed-effects joint
models for longitudinal and time-to-event data with multiple data features. A real
AIDS study data analysis and simulation studies are also involved.
13
Chapter 2 Motivating data set
The Multicenter AIDS Cohort Study (MACS) data motivates this study. It is a prospec-
tive study of the natural and treated histories of HIV-1 infection in homosexual and bisexual
men from 4 metropolitan areas in the Unites States, including Baltimore, Chicago, Pitts-
burgh, and Los Angeles during three recruitment periods (from April 1984 through March
1985, from April 1987 through September 1991, and from October 2001 through August
2003) [64]. Participants in the MACS had baseline and semiannual follow-up visits for a
detailed interview, physical examination, neuropsychological testing, and collection of blood
for laboratory testing. Seroconversion is the interval, several weeks after HIV infection, dur-
ing which antibodies are first produced and rise to detectable levels. The subset of MACS
participants who seroconvert with HIV are of interest, since they are followed up from the
time when they first develop antibodies to HIV. Thus, our data analysis is based on 435
patients with recorded HIV seroconversion, and at least three measures of HIV viral load.
Researchers of the MACS conduct periodic death registry searches to obtain death informa-
tion on all participants, even including those lost to follow up. Time-to-event data for each
patient is also recorded, specifically for death from all causes and corresponding survival
time. Owning to the study design, survival time is recorded at the year level, which is re-
ferred to as interval-censored death times. Table 1 shows the baseline descriptive statistics
of our motivating data set. Of the 435 subjects included in this study, 203 (46.7%) subjects
died during the study period, 416 (95.6%) subjects are recruited from April 1984 through
March 1985 (the first recruitment period), 372 (85.5%) subjects are white, the average age
at seroconversion is 35.46, the median of the baseline log10-transformed viral load and CD4
cell counts are 2.48 and 803, respectively. The average follow-up time of subjects from the
first recruitment period is 12.20 years, which is shorter than that of subjects from the second
recruitment period (14.21 years). To show the general survival information, Kaplan-Meier
14
curves are presented in Figure 2.
Table 1: Baseline descriptive statistics of the motivating data set (MACS)
Variables Total Died Patients Survived Patients
Number of Patients 435 203 232
Recruitment Period
1984− 1985 416(95.63%) 198(97.54%) 218(93.97%)
1987− 1991 19(4.37%) 5(2.46%) 14(6.03%)
Race
White 372(85.52%) 175(86.21%) 197(84.91%)
Non-white 63(14.48%) 28(13.79%) 35(15.09%)
Age at seroconversion
Mean(SD∗) 35.46(8.44) 35.34(8.89) 35.56(8.05)
Baseline log10(viral load)
Median(IQR∗∗) 2.48(1.50) 2.48(0.32) 2.72(1.77)
Baseline CD4
Median(IQR) 803(495) 906(551) 738(451)
∗: Standard deviation.
∗∗: Interquartile range.
Additionally, certain variables were transformed or imputed to benefit our analysis pro-
cess. For example, the viral load was taken a log10 transformation, and CD4 cell counts were
standardized (i.e. each CD4 count is subtracted by mean 556.25 and divided by standard
deviation 325.01) in order to stabilize the variation of the measurements and to accelerate
the convergence of estimation algorithm used in this dissertation. One limitation of the
public MACS data was that time of visit for each patient was only recorded at the year
level. To account for the limitation, according to the study [65], we imputed the visit time
according to the following criteria: (i) if a participant visited twice in year X, the time of
the first visit was recorded as X, and the second visit was computed as X + 0.5; (ii) for a
subject with three visits, time was imputed as X, X+0.33, and X+0.67, respectively. Also,
in order to avoid unstable estimates with extreme value, the original time t was rescaled to
ensure that the time ranges between 0 and 1.
Certain inherent data features, which existed in MACS, make the complicated longi-
tudinal data far from ideal. First, the viral load measurements are often highly skewed,
even after log10 transformation (Figure 3(a)(c)). Second, the small concentration cannot
be precisely measured when the actual quantity is below the limit of detection (LOD) (see
Figure 3(e)), due to the low sensitivity of current technology. Of the 435 subjects with
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Figure 2: Kaplan-Meier curves for all subjects and by race
total 6,437 observations in MACS data we used, 1,680 (26%) viral load data fell below the
LOD (40 copies/ml), which may result in significant biases [39, 66]. Third, covariates in
the longitudinal data may suffer from measurement errors. For example, in AIDS research,
CD4 cell counts are often measured with substantial errors, and ignoring this phenomenon
may lead to biased inference [67–69]. Finally, skewness is also commonly observed in CD4
cell counts (Figure 1(b)(d)), but most of the statistical models assume that the error terms
follow normal distribution because of the computational convenience [67–70]. Although the
findings from those models still dominate the applications, it is well known that the misspec-
ified normal assumption could produce misleading results and lack the robustness [71, 72].
Therefore, since the analysis of such “imperfect” data poses statistical challenges, we have
to pay attention to these data features in the following studies.
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Figure 3: Histogram, QQ plots for 435 subjects with seroconversion from MACS data,
and profiles for five representative patients of viral load in log10 scale (left panel) and
standardized CD4 cell counts (right panel).
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Chapter 3 QR-based nonlinear mixed-effects joint models
for longitudinal-survival data with multiple features
3.1 Introduction
Data collected in many longitudinal medical studies record much information, not only
repeated measures of disease biomarkers, but also survival status and follow-up time of
patients. For example, in HIV/AIDS studies, viral load and CD4 cell counts are important
biomarkers of the severity of viral infection, disease progression, and treatment evaluation.
In addition to the baseline measures, their longitudinal trends may be predictive of the risk
of a terminal event (e.g., a steadily decreasing CD4 accounts may predict adverse events
for HIV patients). Recently, joint models have been developed to assess the longitudinal
process, survival process, and the relationship between them simultaneously, by sharing
the random effects and/or related covariates [73–77]. It is an active area of statistics and
biostatistics research, because of its capability on the bias reduction and estimates’ efficiency
improvement, compared to separate modeling approaches [65,69,72].
The majority of longitudinal modeling methods, both linear and non-linear models, are
typically based on mean regression, which concentrates on the average effect of response
variable conditional on covariates [67–71]. However, the mean trajectory of the longitudinal
outcome may not always be of interest. In fact, in HIV/AIDS research, the effects of
the covariates (e.g., CD4 counts) are more important on the left tail of the distribution
where subjects are at higher risk. Additionally, if obvious outliers and/or heavy tails exist,
mean regression may result in non-robust parameter estimates. For example, in MACS
data, the viral load measurements are often highly skewed, even after log10 transformation
(Figure 3(a)(c)). An effective solution is switching the concentration of mean regression to
conditional quantiles [6,9,78]. QR model, which belongs to a robust family, can offer a full
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scan of covariate effect at different quantiles of the response. As we reviewed in Section 1.2,
longitudinal QR models have been developed via different statistical approach, and applied
to various research areas. Most of them are proposed according to the linearity assumption,
which can be labeled as QR-based LME models. However, the linearity assumption is
sometimes too idea to be true. The non-linear QR for longitudinal data is still rare, thus it
is emergent to generalize the longitudinal QR from linear cases to nonlinear ones.
As we discussed in Chapter 2, some important data features the MACS data showed
should be seriously considered. First, from Figure 3(e), it is obvious that some participants’
viral load are below LOD. Dealing with censored observations, a simple but rough method
is directly omitting or imputing the censored values by either the LOD or some arbitrary
values, such as LOD/2. Instead, in order to get more accurate estimates, we adopt a Tobit
model [66, 79] to solve the left-censoring issue. Second, most of the studies assumed a nor-
mal distribution for the error terms of their models because of the mathematical tractability
and computational convenience [67–70]. The violation of the “normality” assumption could
trigger biased or misleading inference [71, 72]. Compared to symmetric (normal) distribu-
tion, an asymmetric distribution such as SN distribution should be more appropriate in
modeling such “skewed” data [57–59,61]. Third, measurement error in covariate, like CD4
cell counts, is another typical problem in HIV/AIDS longitudinal studies, and ignoring this
phenomenon may lead to biased inference. Various covariate measurement error models
have been investigated in the literature, but the majority of them have been developed us-
ing parametric regression methods. Although such parametric models enjoy the simplicity,
they suffer inflexibility when dealing with complicated longitudinal measures. Nonpara-
metric regression models show the benefit to capture such complicated dynamics by using
flexible function forms.
To the best of our knowledge, no study has done the QR-based nonlinear mixed-effects
joint models for longitudinal-survival data with these data features, including LOD, skewed
covariate with measurement errors. Statistical inference and analysis complicate dramati-
cally when these issues exist simultaneously. In this chapter, thus, we propose a Bayesian
approach for a joint models consisting of (i) QR-based nonlinear mixed-effects models with
the ALD [12] for outcome process; (ii) nonparametric LME model with SN distribution for
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covariate process; and (iii) Cox proportional hazard model for survival process. Approaching
the complicated joint models from Bayesian perspective is more nature and straightforward,
since it avoids many complicated approximations required by the frequentist methods.
3.2 QR-based nonlinear mixed-effects joint models
3.2.1 Nonparametric SN measurement error model for CD4 covariate
In the presence of measurement error and non-normality in CD4 cell counts, we employ a
flexible empirical nonparametric mixed-effects model with SN distribution to quantify the
covariate process. Denote the number of subjects by n and the number of measurements
on the ith subject by ni. Let zij be the observed CD4 covariate value for individual i at
time tij (i = 1, . . . n; j = 1, . . . , ni).
zij = w(tij) + hi(tij) + ij (≡ z∗ij + ij),
i
iid∼ SNni
(
−
√
2/piδ1ni , σ
2
1Ini , δIni
)
,
(3.1)
where zi = (zi1, . . . , zini)
T with zij being the observed CD4 covariate value for individual i
at time tij ; z
∗
i = (z
∗
i1, . . . , z
∗
ini
)T and z∗ij = w(tij) + hi(tij) may be viewed as the true (but
unobservable) covariate value at time tij ; w(tij) and hi(tij) are unknown nonparametric
smooth fixed-effects and random-effects functions, respectively; and i = (i1, . . . , ini)
T
follows a multivariate SN distribution with unknown variance parameter σ21 and skewness
parameter δ, where the location parameter is set as −√2/piδ1ni in order to have a zero
mean vector for error term and 1ni = (1, . . . , 1)
T . It is noticed that we specify the skewness
matrix being δIni , indicating that we are interested in skewness of overall pooled CD4
measurements from all the patients.
Compared to the parametric LME model, the nonparametric LME model (3.1) is more
flexible. The fixed smooth function w(t) represents population average of the covariate
process, while the random smooth function hi(t) is used to incorporate the inter-individual
variation in the covariate process. We assume that hi(t) is the realization of a zero-mean
stochastic process. To fit model (3.1), a regression spline method is applied to w(t) and hi(t),
details can be found in literature [80,81]. Briefly, the working principle of regression spline is
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described as: a linear combination of spline basis functions is used to approximate w(t) and
hi(t). For example, w(t) and hi(t) can be approximated by a linear combination of basis
functions Ψp(t) = {ψ0(t), ψ1(t), . . . , ψp−1(t)}T and Φr(t) = {φ0(t), φ1(t), . . . , φr−1(t)}T ,
respectively. That is,
w(t) ≈ wp(t) =
p−1∑
k=0
αkψk(t) = Ψp(t)
Tα,
hi(t) ≈ hir(t) =
r−1∑
k=0
aikφk(t) = Φr(t)
Tai,
(3.2)
where α = (α0, . . . , αp−1)T is a p × 1 vector of fixed-effects, and ai = (ai0, . . . , ai,r−1)T
(r ≤ p) is a r × 1 vector of random-effects. We assume that ai iid∼ Nk(0,Σa) with Σa
being unrestricted covariance matrix. Based on the assumption of hi(t), ai is regarded as
iid realizations of a zero-mean random vector. We consider natural cubic spline bases with
the percentile-based knots in this model. Selection of optimal degree of regression spline
and numbers of knots, in other words, the optimal sizes of p and r, is determined according
to the Akaike information criterion (AIC) or the Bayesian information criterion (BIC) [80].
Substituting w(t) and hi(t) by their approximations wp(t) and hir(t), we can approxi-
mate model (3.1) by the following nonparametric LME model.
zij ≈ Ψp(tij)Tα+ Φr(tij)Tai + ij ≈ z∗ij + ij ,
i
iid∼ SNni
(
−
√
2/piδ1ni , σ
2
1Ini , δIni
) (3.3)
Following the study of Liu and Wu in 2007 [68], we set ψ0(t) = φ0(t) = 1 and take the
same natural cubic splines in the approximations (3.2) with the degree of regression spline
r ≤ the numbers of knots p (in order to limit the dimension of random-effects). The values
of p and r are determined according to the AIC/BIC criteria. The AIC/BIC values were
evaluated in various models with (p, r) = {(1, 1), (2, 1), (2, 2), (3, 1), (3, 2), (3, 3)}. Among
them, we found that the model with (p, r) = (3, 3) has the smallest AIC/BIC value. Thus,
we adopted the following nonparametric mixed-effects CD4 covariate model,
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zij = (α0 + ai0)ψ0(tij) + (α1 + ai1)ψ1(tij) + (α2 + ai2)ψ2(tij) + ij (≡ z∗ij + ij)
(3.4)
where zij is the observed CD4 value after standardization at time tij , ψ1(·) and ψ2(·) are two
basis functions given in Section 2.2, α = (α0, α1, α2)
T is a vector of population (fixed-effects)
parameters, ai = (ai0, ai1, ai2)
T is a vector of individual (random-effects) parameters, and
ij is the measurement error at time tij following an SN distribution.
3.2.2 The QR-based nonlinear mixed-effects models for viral response
We use yij to denote the log10-transformation of the response variable, viral load, for the i
th
subject at time tij (i = 1, 2, ..., n, j = 1, 2, ..., ni). To introduce the Tobit model accounting
for the left-censoring data in our joint models framework, we denote the observed value yij
by (qij , cij), where cij is the censoring indicator and qij is the latent response variable. The
latent qij is observed, as yij , then cij = 0, if and only if yij > ζ (a known constant LOD,
log10(40) = 1.602 in our data example). Otherwise, yij is treated as missing value, and
cij = 1.
Viral load dynamic models can be formulated by a series of ordinary differential equa-
tions (ODE) [82, 83]. Wu [82] offered some arguments biologically for a two-compartment
viral dynamic model where two phases of viral load decay are discussed. With certain
reasonable assumptions, a simplified approximated ODE has been proposed as follows to
capture the viral load trajectory.
y(t) = log10(e
p1−λ1t + ep2−λ2t), (3.5)
where y(t) denotes the log10 transformed viral load levels at time t. λ1 and λ2 are the first-
and second-phase viral decay rates, which may represent the minimum turnover rate of
productively infected cells and that of latently or long-lived infected cells, respectively [84].
The parameters p1 and p2 are macro-parameters, and e
p1 + ep2 represents the viral load
at the baseline with time t = 0. It is commonly assumed that λ1 > λ2, which makes
the model be identifiable and appropriate for empirical research [82]. We noted that the
trajectories of viral load are dramatically different. For some patients, viral loads decrease
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at the beginning and then increase indicating a viral rebound; but the viral load responses
of some other patients decrease over time and stay at a relatively low level. It suggests
that the second-phase viral decay rate λ2 may vary over time, and variation in the dynamic
parameters, particularly λ2, may be partially associated with time-varying covariates such
as repeated CD4 cell counts. Thus, it may not be reasonable to assume that second-phase
viral decay rate λ2 is a constant since the viral load varies at the later stage during a long-
term treatment. To model the complicated long-term HIV dynamics, a natural extension
of equation (3.5) assuming that the second-phase viral decay rate λ2 changes over time, is
applied, which is a function of time-varying CD4 counts. Thus, we determine to apply the
following QR-based nonlinear mixed-effects model for the viral load response.
yij = log10(e
pi1−λi1tij + epi2−λij2tij ) + eij
pi1 = β1 + bi1, λi1 = β2 + β3zi0 + bi2,
pi2 = β4 + bi3, λij2 = β5 + β6z
∗
ij + bi4,
(3.6)
where zi0 and z
∗
ij are the baseline CD4 counts and true (but unobservable) value of CD4
covariate for the ith subject at time tij ; β = (β1, β2, . . . , β6)
T and βij = (pi1, pi2, λi1, λij2)
T
are population (fixed effects) parameters and individual-specific (random effects) parameters
for the ith subject at time tij , respectively; ei = (ei1, . . . , eini)
T is the vector of within-
individual random error with eij following ALD(0, σ, τ), which is restricted to have the
τth quantile equal to 0 with the scale parameter σ(> 0), i.e., Qeij (τ |bi; tij , zij , zi0) = 0,
where Qeij (τ |·) ≡ F−1eij (τ |·) is the inverse cdf of eij esimated at τ ; bi = (bi1, . . . , bi4)T is
random-effects following N4(0,Σb) with Σb being unrestricted covariance matrix.
3.2.3 Cox proportional hazard model for survival data
Cox proportional hazard model is adopted for time-to-event process. We assume that
the distribution of Ti, the death time for the i
th subject, depends on the random-effects
bi, representing individual-specific longitudinal processes, and other survival covariates xi,
respectively. We therefore consider a frailty model for Ti, which is linked to viral load
process (3.6) through the random-effects bi. Additional covariates xi are assumed to be
associated with the risk of death but not with the longitudinal measurements. Specifically,
in the survival process, the conditional hazard rate of Ti at time ti is expressed as
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λ(ti|bi,xi) = λ0(ti) exp(γT1 bi + γT2 xi) = λ0(ti) exp(γTdi), (3.7)
where λ0(ti) is the baseline hazard function, di = (b
T
i ,x
T
i )
T , γ = (γT1 ,γ
T
2 )
T , γ1 and γ2
are unknown parameters linking the random-effects bi and covariates xi to the conditional
hazard rate, respectively.
Let ρi = (ρi1, . . . , ρini)
T be a vector of censoring (’death’) indicator for individual i:
ρij = 1 if the patient has died by time tij , otherwise, ρij = 0. We assume that ρi1 = 0
for all subjects. In the MACS example, for individual i, let Ti be the time to death and
assume P (Ti <∞) = 1, but it is not exactly recorded due to the limitation of study design.
This type of survival time is usually called interval-censored death time. Specifically, if
the death of individual i is recorded at time tij , it means that the true death time Ti
takes place during the time period (ti,(j−1), tij ], that is, ti,(j−1) < Ti ≤ tij . Also, we take
ρi1 = . . . = ρi,(j−1) = 0 and ρij = . . . = ρini = 1. If no such event (death) has happened,
we treat ρij = 0 for j = 1, . . . , ni, and thus Ti > tini .
From equation (3.7), the probability of time-to-death is given as
pij = P (ρij = 1|ρij∗ = 0, 0 ≤ j∗ < j) = 1− P (Ti ≥ tij |Ti > ti,j−1)
= 1− P (Ti ≥ tij)
P (Ti ≥ ti,j−1) = 1− exp
(
−
∫ tij
ti,j−1
λ0(t)dt exp(γ
Tdi)
)
= 1− exp(−exp(γ0j + γTdi)),
(3.8)
where γ0j = log
(∫ tij
ti,j−1 λ0(t)dt
)
, j = 1, . . . , ni. Given the current observation mechanism,
only the finite number of parameters γ0j are required to handle, instead of the unknown
baseline hazard function λ0(t) in the parameter estimation-based method. The contribution
to the likelihood from the time-to-death part for the ith subject is denoted by f(ρi|di).
Thus, we have
f(ρi|di) =
∏ni
j=1 f(ρij |ρij∗ , 0 ≤ j∗ < j;di), (3.9)
where f(ρij |ρij∗ , 0 ≤ j∗ < j;di) = pρijij (1 − pij)1−ρij and ρij equals to 0 before death and
1 after death. Let νi = max(tij : ρij = 0) and uij = min(tij : ρij = 1). With (3.9), the
following probability of time-to-death can be expressed as
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P (νi < Ti ≤ ui|di) =exp
(
−
∫ νi
0
λ0(t)dt exp(γ
Tdi)
)
·
[
1− exp
(
−
∫ ui
νi
λ0(t)dt exp(γ
Tdi)
)]
,
(3.10)
where ui =∞ if ρij = 0 for j = 1, . . . , ni. The process we discussed above is an alternative
way to approximate the Cox proportional hazard model through counting process [85].
In detail, we assume that the survival time Ti for the i
th subject depends on the random-
effects bi and other survival covariates xi. Other baseline covariates include age at sero-
conversion (agei), and race (racei), with racei = 1 if subject i is white, and racei = 0
otherwise. To avoid extremely heavy computational load, we do not put random-effects ai
and other covariates into the model. Therefore, the Cox submodel (3.7) is specified as
λ(ti|bi,xi) = λ0(ti) exp(γ1bi2 + γ2bi4 + γ3agei + γ4racei), (3.11)
where γ = (γ1, . . . , γ4)
T is the parameters corresponding to the random-effects (bi2, bi4),
covariates (agei, racei). It is noted that the random-effects bi2 and bi4 represent individual
variations in the first- and second-phase viral load decay rates, respectively, which may be
predictive for survival time. Since bi1 and bi3 represent variations in the baseline viral loads,
which do not appear to be highly correlated to the risk of death, to reduce the number of
parameters, they are excluded from model (3.11).
3.3 Simultaneous Bayesian inferential approach
Estimation of a longitudinal-survival joint models could be conducted in two general ways.
The first estimation approach is based on the likelihood inferential methods, such as EM
and MCEM algorithm [35,86]. Although these methods for joint models with multiple data
feature may be favourable, the computational cost for such a complicated model is extremely
intensive, and particularly, may lead to convergence problem [69]. The second method is
Bayesian inferential approach, which may be more natural to deal with such complex models,
simpler to implement when prior information is available, and overcome the convergence
problem. Thus, we propose a fully Bayesian framework for the joint modeks, which consists
of covariate measurement error model (3.1), QR-nonlinear mixed-effects model (3.6), and
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Cox proportional hazard model (3.7), to simultaneously estimate parameters. We obtain
numerical approximations to posterior distributions using MCMC procedure.
We assume that i, ei, ai and bi are independent of each other mutually. To specify
the joint models for MCMC procedure, we introduce wi = (wi1, . . . , wini)
T and vij based
on the stochastic representations in equations (1.16) and (1.5) presented in Chapter 1, we
hierarchically formulate the joint models (3.1), (3.6), and (3.7) as follows
yij |zij , bi,ai, vij ∼ N
(
g(tij ,βij) + ϑ1vij , ϑ2σvij
)
,
zij |ai, wij ∼ N(z∗ij + δ(wij −
√
2/pi), σ21),
ai ∼ N3 (0,Σa) , bi ∼ N4 (0,Σb) ,
wij ∼ N(0, 1)I(wij > 0), vij ∼ Exp( 1σ ),
Ti ∼ F (ti|di) =
∫
f(ρi|di),
(3.12)
where g(tij ,βij) = log10(e
pi1−λi1tij + epi2−λij2tij ) described in equation (3.6), ϑ1 = (1 −
2τ)/[τ(1− τ)] and ϑ2 = 2/[τ(1− τ)]; I(wij > 0) is an indicator function and wij ∼ N(0, 1)
truncated in the space wij > 0 (i.e., standard half-normal distribution).
Denote θ = {α,β,γ, σ21, σ,Σa,Σb, δ} as the collection of unknown population parame-
ters in models (3.1), (3.6), and (3.7). Under the Bayesian framework, the following prior
distributions are specified for all of the unknown parameters
α ∼ N3(α0,Ω1), β ∼ N6(β0,Ω2), γ ∼ N4(γ0,Ω3),
σ ∼ IG(ω1, ω2), σ21 ∼ IG(ω3, ω4),
Σa ∼ IW (Ω4, ω5), Σb ∼ IW (Ω5, ω6), δ ∼ N(0, ω7),
(3.13)
where the Normal (N), Inverse Gamma (IG) and Inverse Wishart (IW ) prior distributions
are chosen to accelerate the computation. The hyper-parameter matrices Ωk (k = 1, . . . , 5)
can be assumed to be diagonal for convenient implementation.
Let f(·), f(·|·), F (·|·) and pi(·) denote a density function, a conditional density func-
tion, a cumulative density function (c.d.f) and a prior density function, respectively. We
assume that α,β,γ, σ21, σ,Σa,Σb and δ are independent of each other, then we have pi(θ) =
pi(α)pi(β)pi(γ)pi(σ21)pi(σ)pi(Σa)pi(Σb)pi(δ). After specifying the prior distributions and joint
models with the observed data, we can make Bayesian statistical inference for these param-
eters based on their posterior distributions. Thus, the joint posterior density of θ based on
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the observed data D = {(yij , cij , zij , zi0, xi, ρij), i = 1, . . . , n; j = 1, . . . , ni} can be given by
f(θ|D) ∝ {
n∏
i=1
∫ ∫ ni∏
j=1
f(yij |zij , bi,ai, vij)1−cijF (ζ|zij , bi,ai, vij)cij
f(zij |ai, wij)f(ρi|di)f(bi)f(ai)f(vij)f(wij |wij > 0)dbidai}pi(θ).
(3.14)
Generally, since the integrals in (3.14) are high dimensional, they may not have a closed
form. Analytic approximations to these integrals may not be sufficiently accurate. Thus,
it is prohibitive to calculate the posterior distribution directly based on the observed data.
Alternatively, we can use the MCMC procedure to sample population-level parameters θ,
and random-effects ai and bi (i = 1, . . . , n), from the posterior distributions based on
(3.14), by utilizing the Gibbs sampler and the Metropolis-Hastings (M-H) algorithm. This
process is repeated in iterations of MCMC procedure until convergence is reached. An
important advantage of the above representations based on the joint models is that they are
easily implemented using the public and freely available WinBUGS software [87] interacted
with a function called bugs in a package named R2WinBUGS of R. Another advantage
is that when WinBUGS software is used to implement our modeling approach, it is not
necessary to explicitly specify the full conditional posterior distributions for parameters to
be estimated. Although their derivations are straightforward by working the complete joint
posterior (3.14), some cumbersome algebra will be involved. We, thus, omit them here to
save space.
3.4 Application to MACS data
3.4.1 Model implementation
Chapter 2 has briefly described the MACS data set that motivated this research. As showed
in Figure 3(b)(d) previously, the covariate CD4 cell counts exhibits the asymmetric feature.
It is plausible to fit the data by considering covariate model error with an SN distribution.
Furthermore, although the outcome variable viral load also exhibits skewness and outliers,
we specify ALD instead of the SN distribution in order to construct a QR-based model. From
the biological perspective, the longitudinal process and time-to-event process are inherently
connected. Toward the end, the following two joint models with different distributions were
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applied to compare their performance:
• Model SN: eij and ij follow ALD and SN distribution, respectively.
• Model N: eij and ij follow ALD and normal distribution, respectively.
Since a normal distribution is a special case of an SN distribution when skewness parame-
ter is zero, we investigate how the covariate model (3.1) with an asymmetric SN distribution
contributes to modeling results and parameter estimation, in comparison with that using a
symmetric normal distribution.
To specify the values for the hyper-parameters in the prior distributions (3.13), the
weakly informative prior is employed for the unknown parameters. In particular, (i) the
priors for each element of the fixed-effects α, β, and γ are taken independent normal
distribution N(0, 100); (ii) inverse Gamma prior distribution IG(0.01, 0.01), which has mean
1 and variance 100, is chosen for scale parameter σ and σ21; (iii) inverse Wishart distributions
IW (diag(0.01, 0.01, 0.01), 3) and IW (diag(0.01, 0.01, 0.01, 0.01), 4) are specified as the priors
for the variance-covariance matrices of the random-effects Σa and Σb, respectively; (iv) a
normal distributions N(0, 100) is chosen for the skewness parameter δ.
The MCMC sampler was implemented using WinBUGS software [87] interacted with
R2WinBUGS of R software, and the program code is attached as Appendix A. When the
MCMC procedure was applied to the read data (MACS), convergence of the generated
samples was assessed using standard tools within WinBUGS software such as trace plots
and Gelman-Rubin (GR) diagnostics [88]. Figure 4 shows the trace plots, autocorrelation
and dynamic version of GR diagnostic plots based on Model SN for the representative
parameters β1, α2, γ4, and δ. We observe from trace plots (left panel) that the lines of
three different chains mix together in trace, which implies that convergence is reached. In
the plots of GR diagnostics (middle panel), three curves are showed: the bottom and middle
curves below the horizontal line with the value one represent the pooled posterior variance
(Vˆ ) and average within-sample variance (Wˆ ), respectively, and the top curve represents
their ratio (Rˆ). Rˆ is generally expected to be higher than one at the initial stage, then
Rˆ tends to 1, and Vˆ and Wˆ stabilize as the number of iterations increase. This indicates
that the algorithm has met convergence. Furthermore, autocorrelation plots (right panel)
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is also monitored, that autocorrelations are very low with a lag being 50, indicating that
convergence is reached.
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Figure 4: Convergence diagnostics for representative parameters based on QR-based non-
linear mixed-effects joint models (Model SN) with τ = 0.5: trace plots (left panel); Auto-
correlation plots (middle panel); Gelman-Rubin (GR) diagnostic plots (right panel)
After an initial number of 100,000 burn-in iterations of three chains with length 150,000,
every 50th MCMC sample was retained from the next 50,000 for each chain. Finally,
we obtained a total of 3,000 samples of targeted posterior distributions of the unknown
parameters for statistical inference. In the real data analysis where n = 435, the computing
time necessary to fit the proposed model can range up to around 3 days on a Windows PC
with Intel Core i7-6700 CPU @ 3.40 GHz and RAM of 16 GB. In the following section, we
report the results based on the two scenarios highlighted above.
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3.4.2 MACS data analysis results
Bayesian joint modeling approach in conjunction with the QR-based nonlinear mixed-effects
models at the five quantiles of τ = 0.05, 0.25, 0.50, 0.75 and 0.95 is used to fit the viral load,
CD4 cell counts, and survival data jointly. Table 2 presents the population posterior mean
(PM), the corresponding 95% credible interval (CI) for fixed-effects parameters based on
the two proposed models (N and SN). The following findings are obtained for the results of
estimated parameters.
According to the results from Models N and SN at five quantiles of τ = 0.05, 0.25, 0.50, 0.75
and 0.95 in Table 1, interesting findings are discovered. First, as τ increases, due to the
increase of β1 and β4 (except β1 at τ = 0.95), the baseline viral load, e
p1 + ep2 , increases.
Second, the estimates of β2 and β3, which are parameters associated with the first-phase
viral decay rate, have the smallest value at median (τ = 0.50), and increase as quantile goes
extremely (in both directions) with the largest value at τ = 0.95. It indicates that the first-
phase viral decay rate increases at more extreme quantiles of the viral load. Third, similar
to the first-phase viral decay rate, the second-phase viral decay rate is also the smallest at
median (τ = 0.50), and becomes larger at more extreme quantiles (τ = 0.05 and τ = 0.95).
Overall, the first-phase and the second-phase viral decay rates are varying through the five
different quantiles, and the highest are found at quantile τ = 0.95. In comparison of Models
N and SN at the same quantile, the estimated results indicate that β1, β3, and β4 (except
when τ = 0.75) in Model N are larger than their counterparts in Model SN; in contrast, β2,
and β5 (except when τ = 0.50) in Model N is smaller than its counterpart in Model SN.
For the parameters in the covariate measurement error model (3.4) in Model N or
Model SN at the five quantiles of τ = 0.05, 0.25, 0.50, 0.75 and 0.95, the estimated results
are comparable. In comparison of Model N with Model SN at the same quantile of τ , the
estimated α1 in Model N are slightly smaller than their counterparts in Model SN, while
the estimated α2 and α3 in Model N is larger than its counterpart in Model SN. Figure 5(a)
shows the difference between population-level estimated CD4 trajectories based on Model
N and Model SN at median (τ = 0.50). In addition, it can be seen that as τ increases, the
estimated skewness parameter δ with significantly positive value slightly decreases. This
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Table 2: Summary of estimated posterior mean (PM) of population (fixed-effects) parame-
ters, the corresponding lower limit (LCI) and upper limit (UCI) of 95% equal-tail credible
interval (CI) as well as DIC values for QR-based nonlinear mixed-effects joint models.
Method Model β1 β2 β3 β4 β5 β6 α1 α2 α3 γ1 γ2 γ3 γ4 δ DIC
τ = 0.05
JM N PM -43.92 20.13 -3.81 -45.97 5.69 3.00 -0.06 0.65 -64.92 -0.09 -0.03 0.14 0.18 – 81980.9
LCI -47.89 12.89 -8.29 -49.74 0.22 0.82 -0.14 -14.36 -82.99 -1.36 -1.28 -0.03 -0.23 –
UCI -42.30 30.60 2.82 -43.75 9.71 5.02 0.03 15.60 -48.23 1.34 1.27 0.30 0.63 –
JM SN PM -53.91 26.01 -4.91 -56.58 8.33 4.75 -0.05 -7.26 -67.99 -0.12 -0.09 0.14 0.18 0.86 75486.9
LCI -57.41 17.41 -8.89 -60.33 1.97 1.48 -0.12 -21.93 -85.91 -1.34 -1.40 -0.02 -0.23 0.83
UCI -52.02 37.05 2.07 -54.04 13.33 7.83 0.04 7.34 -50.71 1.12 1.16 0.30 0.63 0.89
τ = 0.25
JM N PM 1.45 6.68 -2.27 -11.33 2.08 -2.76 -0.05 1.08 -62.57 -0.29 0.11 0.28 0.24 – 65703.4
LCI 1.03 4.57 -6.10 -24.92 -3.09 -8.14 -0.13 -13.65 -79.58 -1.03 -1.11 0.07 -0.33 –
UCI 1.97 8.30 -0.47 -3.37 5.87 2.04 0.04 15.64 -46.21 0.39 1.13 0.50 0.82 –
JM SN PM -1.83 9.40 -2.62 -14.33 4.21 -4.07 -0.04 -7.67 -64.61 -0.23 0.13 0.28 0.24 0.86 62723.5
LCI -2.42 6.64 -6.61 -27.99 -0.65 -10.93 -0.11 -21.96 -80.38 -0.76 -0.88 0.08 -0.33 0.82
UCI -1.12 11.32 -0.65 -6.30 8.29 2.51 0.03 6.76 -46.81 0.38 1.11 0.48 0.81 0.88
τ = 0.50
JM N PM 10.92 5.48 -3.66 1.91 -0.15 0.23 -0.05 0.57 -61.92 -0.14 0.03 0.30 0.27 – 61876.1
LCI 10.59 3.03 -6.21 -3.21 -4.69 -1.65 -0.13 -17.12 -78.06 -0.36 -1.02 0.10 -0.32 –
UCI 11.25 7.48 -1.74 5.85 3.55 2.11 0.04 16.04 -44.90 0.06 1.06 0.52 0.91 –
JM SN PM 9.07 7.59 -4.92 -1.57 -1.01 0.60 -0.04 -6.16 -66.39 -0.13 0.03 0.31 0.28 0.85 59069.5
LCI 8.59 4.74 -8.23 -5.57 -5.58 -1.94 -0.11 -20.69 -80.97 -0.32 -0.96 0.10 -0.28 0.82
UCI 9.54 10.32 -2.23 1.80 3.15 3.10 0.04 8.06 -51.65 0.01 1.04 0.52 0.89 0.88
τ = 0.75
JM N PM 20.61 6.58 -2.88 4.53 0.37 -3.16 -0.05 -1.29 -65.22 -0.21 0.03 0.28 0.25 – 66570.1
LCI 20.15 4.16 -5.95 -15.73 -4.98 -10.76 -0.14 -17.80 -81.00 -0.73 -0.98 0.08 -0.32 –
UCI 21.07 8.42 -0.79 13.56 4.86 2.21 0.04 15.02 -47.54 0.15 1.10 0.49 0.81 –
JM SN PM 19.14 9.64 -2.09 6.09 3.90 -9.54 -0.04 -7.92 -65.39 -0.20 0.19 0.25 0.24 0.85 62192.1
LCI 18.65 7.77 -3.63 -13.81 -1.51 -15.50 -0.12 -22.72 -81.48 -0.81 -0.67 0.05 -0.29 0.82
UCI 19.62 11.50 -0.69 15.19 7.97 -4.31 0.03 7.22 -48.08 0.51 1.13 0.45 0.82 0.88
τ = 0.95
JM N PM 0.25 27.71 -0.77 46.72 8.89 4.07 -0.06 -1.21 -67.67 -0.04 -0.34 0.19 0.22 – 77245.6
LCI -19.08 19.53 -7.37 46.08 6.88 2.45 -0.14 -21.93 -84.58 -1.09 -0.97 0.01 -0.27 –
UCI 19.61 37.20 8.19 47.38 10.88 5.69 0.03 14.79 -49.14 0.98 0.39 0.38 0.72 –
JM SN PM 0.02 31.68 -1.84 45.78 11.08 6.04 -0.03 -7.06 -60.83 -0.06 -0.41 0.17 0.22 0.85 71012.9
LCI -20.13 23.38 -8.60 44.96 8.50 3.77 -0.10 -20.90 -79.58 -1.24 -1.35 0.00 -0.24 0.82
UCI 19.94 41.62 7.42 46.60 13.56 8.35 0.06 7.16 -44.56 1.08 0.59 0.35 0.72 0.88
finding suggests that there is a significantly positive skewness on the CD4 data and confirms
the fact that the distribution of the original CD4 data is right-skewed. Thus, incorporating
a skewness parameter in the modeling of the CD4 covariate data is recommended.
In the time-to-death model (3.11), generally, estimates of all parameters vary through
the different quantiles, and Model N and Model SN are comparable at the same quantile.
Specifically, from Model SN, the estimated results show that age at seroconversion (γ3) is
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significantly associated with risk of death at all quantiles, except τ = 0.05. The strongest
association is found at the median (τ = 0.50), and decreases as quantile goes extremely
(in both directions) with the weakest and non-significant association at τ = 0.05. This
indicates that age at seroconversion is a risk factor of death in general, but not for patients
with extremely low viral load. No such significant association and trend is detected for γ1,
γ2, and γ4.
To select the “best” model (fits the data the most adequately), a Bayesian selection
criterion, known as deviance information criterion (DIC) suggested by [89], is used. As
with other model selection criteria, we caution that DIC is not intended for identification
of the “correct” model, only which one fits the data better. In order to investigate whether
Model SN can provide better fit to the data than Model N, the DIC values are summarized
in Table 2. We found that for the same quantile of τ , both of the DIC in Model SN are
smaller than their counterparts in Model N. In addition, the smallest DIC is found in Model
SN at the median τ = 0.50, while the largest at the quantile of τ = 0.05. This is explained
by the smaller amount of information available at more extreme quantiles. In summary,
our results suggest that it is very important to assume an SN distribution for the CD4
covariate model in order to achieve more reliable results, especially when the CD4 data
exhibits non-normality.
For a specific application, we further report results of Model SN at the quantile of
τ = 0.50. The estimated results indicate that the population level CD4 trajectory may
be approximated by the nonparametric mixed-effects model zˆ∗(t) = 325.01(−0.04ψ0(t) −
6.16ψ1(t) − 66.39ψ2(t)) + 556.25, where zˆ∗(t) is in the original CD4 scale (Figure 4(a)).
The estimated population level first- and second-phase viral decay rates are λˆ1 = 7.59 −
4.92z0 and λˆ2(t) = −1.01 + 0.60zˆ∗(t). Thus, the population viral load process may be
approximated by Vˆ (t) = exp(9.07 − λˆ1t) + exp(−1.57 − λˆ2(t)t) (Figure 4(b)). Because
the first-phase viral decay rate (λ1) is negatively associated with the baseline CD4 counts,
it suggests that the viral load change V (t) may be also significantly associated with the
baseline CD4 values. Note that this simple approximation considered here may provide a
rough guidance and point to further research even though the true association described
above may be complicated. For the covariate measurement error model, the estimate of
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skewness parameter δ is 0.85 with 95% credible interval: 0.82-0.88, indicating significantly
positive skewness. Furthermore, the estimates of parameters in the time-to-death model
indicate that higher age at seroconversion will significantly increase the risk of death (Hazard
ratio =1.36, 95% credible interval: 1.11-1.68). Neither of viral load changes over time and
race were found to be significantly associated with the risk of death.
0 5 10 15 20
45
0
50
0
55
0
60
0
65
0
t
z 
*
(t)
(a): Estimated CD4 trajectories in Model SN and N
SN
N
0 5 10 15 20
0
20
00
40
00
60
00
80
00
t
V 
(t)
(b): Estimated viral load trajectory in Model SN
Figure 5: The population-level estimated CD4 and viral load trajectories at median (τ =
0.50)
3.5 Simulation studies
To assess the performance of the proposed joint models, as an illustration, we conduct
the following limited simulation studies. The simulated data is similar to the motivating
data. Specifically, we generate the data with sample size n =300, and assume that each
subject had 23 scheduled longitudinal measurements. The simulated measurement time
points are similar to those in the real data analysis, and the true parameter values are
selected as follows: β = (β1, . . . , β6)
T = (9, 30,−10,−16, 28,−19)T , α = (α1, α2, α3)T =
(5,−15,−70)T , γ = (γ1, . . . , γ4)T = (1, 1, 5, 5)T , (bi1, . . . , bi4)T ∼ N(0,diag(1, 1, 1, 1)). The
time-varying CD4 covariate zij are generated based on equation (3.4) with (ai1, ai2, ai3)
T ∼
N(0,diag(1, 1, 1)); we simulate the model errors eij and ij from a Γ(1, 0.5) distribution,
then subtract by 0.5, which yields a skewed distribution with the mean 0 and variance 2. To
generate the survival data, a constant baseline hazard 0.1, and an exponential distribution
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with mean equal to 0.1 are used to generate censoring time. Other covariates in Cox
regression model, race and age, are simulated from a Bernoulli distribution with p = 0.8,
and a normal distribution with mean 35 and standard deviation 8, respectively. To simulate
the left-censoring data, we select the 20% quantile of the longitudinal response as a cut-
of threshold, which ensures that 20% of the data is below LOD. According to the settings
described above, we only simulate 20 data sets due to exertive computation, and fit the data
by Model SN and Model N at three different quantiles of τ = 0.25, 0.50 and 0.75. Note that
the prior distributions considered are all non-informative, and same as those in real data
analysis. Thus, we expect the results to be robust with respect to prior distributions. Table 3
summarizes simulation results which include the true parameter (TP) values, percent bias
(defined by 100 × biasl/|TPl|) and percent mean-square-error (MSE) (defined by 100 ×
√
MSEl/|TPl|) of fixed-effects β, α and γ .
The magnitude of β1 and β4, which indicate that baseline viral load for the first and sec-
ond phase, respectively, are increasing as the quantiles getting larger. The bias of these two
intercept parameters at τ = 0.25 and 0.75 is understandable, because the data is simulated
by the mean-regression based model (the estimates of parameters from median regression
based models are less biased than those from 25th and 75th QR-based models). For all
scenarios considered in this simulation study, it is of interest to see that all estimated biases
for β2 are negative, indicating that these parameters are underestimated, while estimated
biases for β3 and β6 are positive, suggesting that these parameters are overestimated. Since
β3 is the coefficient of baseline CD4 which is related to the first-phase decay rate and β6
is the coefficient of time-varying CD4 covariate which is associated with the second-phase
decay rate, it might suggest that both of the first-phase decay rate and the second-phase
decay rate appear overestimated during the each period of process. However, β5 are slightly
overestimated in Model SN for all quantiles, and underestimated in Model N.
Similarly, for the parameters in the covariate measurement error model, α2 and α3 are
overestimated, and Model SN outperforms Model N in terms of estimates, bias and MSE,
suggesting that it is critical important for covariate model with an SN distribution in order
to achieve more accurate and reasonable estimates when the CD4 cell counts exhibit non-
normal pattern. This finding may also be explained by the fact that the estimated skewness
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Table 3: Summary of true parameter (TP) values, estimated parameters, bias and MSE for
Models N and SN based on 20 simulated data sets
TP Model N Model SN
τ = 0.25 τ = 0.50 τ = 0.75 τ = 0.25 τ = 0.50 τ = 0.75
β1 = 9 Bias -90.73 22.80 135.89 -90.18 21.80 136.02
MSE 90.74 22.82 135.90 90.19 21.84 136.03
β2 = 30 Bias -28.76 -23.32 -27.64 -28.29 -21.97 -27.64
MSE 29.38 23.68 28.52 28.66 22.42 27.67
β3 = −10 Bias 27.25 23.30 25.67 27.23 20.59 25.62
MSE 27.43 23.40 26.02 27.36 20.88 25.63
β4 = −16 Bias -61.66 3.34 63.40 -55.32 3.04 67.34
MSE 61.71 3.51 63.47 55.37 3.94 67.35
β5 = 28 Bias -5.99 -3.49 -6.49 5.75 4.41 1.59
MSE 6.28 4.22 8.19 6.12 5.16 2.02
β6 = −19 Bias 1.97 1.35 1.22 1.10 0.58 1.07
MSE 2.09 1.43 1.56 1.13 0.71 1.14
α1 = 5 Bias 0.31 0.24 -0.25 -0.89 0.28 2.34
MSE 1.15 1.38 0.88 2.93 1.47 2.84
α2 = −15 Bias 40.68 39.41 35.01 9.14 8.93 9.15
MSE 45.01 56.44 47.53 11.60 10.22 11.92
α3 = −70 Bias 7.94 4.47 8.54 0.88 0.63 0.92
MSE 9.12 4.82 10.07 1.32 1.09 1.17
γ1 = 1 Bias 0.41 0.39 0.43 0.40 0.39 0.45
MSE 0.54 0.48 0.49 0.45 0.49 0.57
γ2 = 1 Bias 0.55 0.41 0.64 0.60 0.42 0.68
MSE 0.72 0.62 0.77 0.76 0.69 0.77
γ3 = 5 Bias 0.24 0.23 0.23 0.24 0.24 0.26
MSE 1.52 1.22 1.47 1.55 1.19 1.50
γ4 = 5 Bias 0.34 0.27 0.32 0.31 0.19 0.27
MSE 1.53 1.32 1.44 1.32 1.10 1.20
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parameter δ = 0.73, 0.72, 0.73 for τ = 0.25, 0.50, 0.75, respectively, in Model SN. It confirms
the significantly right-skewed covariate data. All parameters in the survival component are
slightly overestimated in both models, and comparable among different scenarios.
Overall, the simulation results indicate that median regression-based models (i.e., τ =
0.50) outperform its counterparts (i.e., τ = 0.25, 0.75), while QR-based models with τ = 0.25
and 0.75 are comparable in general. Also, we found that the proposed Model SN provides
less biased results compared with Model N. In summary, our simulation results may suggest
that it is important to use the QR-based nonlinear mixed-effects joint models where the
covariate measurement error model is assumed to have SN distribution, in particular, when
the covariate exhibits skewness.
3.6 Concluding discussion
In this chapter, we presented a QR-based nonlinear mixed-effects joint models with three
components (response, covariate, and survival processes) linked through the random-effects
under a Bayesian framework. Compared to the traditional mean-regression based joint mod-
els, our QR-based nonlinear mixed-effects joint models can fully scan the varying nonlinear
viral load dynamics at different quantiles. For example, the first-phase and the second-phase
viral decay rates are greatly distinct at five different quantiles, where the highest is found
at quantile τ = 0.95. It indicates that antiretroviral treatment (ART) is more effective
for HIV patients with higher viral load. Interestingly, the first-phase and the second-phase
viral decay rates are relatively high at quantile τ = 0.05. This suggests that patients should
receive the treatment as early as possible when the viral load is low. Additionally, higher
age at seroconversion is associated with the higher risk of death, and the strength of this
association varies through different quantiles. Furthermore, we considered SN distribution
in covariate measurement error model, instead of normal distribution, when our covariate
CD4 exhibits skewness. The Model SN performs better than Model N in both the real data
analysis and the simulation studies, and provides more accuracy in parameter estimation.
In Bayesian analysis, sensitivity analysis is important to check the robustness of the
posterior estimates when assuming different priors. We performed sensitivity analysis by
adopting a few sets of different values for the hyper-parameters of fixed-effects parameters
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α, β, and γ in (3.13). Particularly, independent normal distribution N(0, 10) and N(5, 100)
are chosen for each element of them. The close results give us confidence that the posterior
estimates are robust to different priors.
Some limitations of this study have to be addressed. First, treatment information is
not included in the real data analysis. Lack of this important information may lead to bad
model fit. Although this study is a methodology study, we will try to obtain and consider
the treatment information in further studies. Second, in simulation studies, the bias of the
first phase parameters β1, β2, and β3 is relatively larger than those in the second phase.
It can be partially explained by the LOD effect. In our simulated data set, the simulated
viral load starts at a low level, then increases as time goes. As a result of this simulated
trajectory, the majority of the value below the LOD exists in the first phase.
In conclusion, this chapter combined new technologies in mathematical modeling and
statistical inference with advances in HIV/AIDS dynamics to quantify complex HIV disease
mechanism.
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Chapter 4 QR-based partially linear mixed-effects joint
models for longitudinal data with multiple features
4.1 Introduction
In HIV/AIDS studies, as important biomarkers of AIDS pathogenesis, severity of viral in-
fection, and disease progression, repeatedly measured viral load and CD4 cell counts have
been widely studied [67–71]. The relationship between them is also of interest, which may
help clinicians better understand AIDS pathophysiology, and evaluate treatment effect. Al-
though the negative relationship is widely accepted, it just measures a very general and
rough mean relationship. In fact, the effect of CD4 counts is more important among sub-
jects with higher viral load, who are at higher risk. Thus, it is desirable to develop new
models to give this relationship a full scan and have a comprehensive understanding. Lon-
gitudinal QR models have been proposed to answer the research questions. Parametric
regression methods for longitudinal data have been well developed in the last 30 years.
Like the QR-based nonlinear mixed-effects joint models we presented in Chapter 3, a major
limitation of these methods is that when the relationship of the longitudinal outcome to
covariates is assumed fully parametric, they have suffered from the inflexibility and pos-
sible misspecification in modeling complicated longitudinal data. For example, in MACS
data, as showed in Figure 3(e), the longitudinal trajectory of viral load for each patient is
quite irregular. Thus, to weaken model assumption, it is more appropriate to model such
varying trajectories by a flexible nonparametric function of time. However, if we consider
nonparametric functions for all covariates, it may bring the problem known as “curse of di-
mensionality”. Also, the parametric relationship between viral load and CD4 cell counts is
of interest. With this consideration, we adopt a PLMM which has received much attention
in statistics [90–93]. In this study, the PLMM serves as an intermediate class of models
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with good robustness by nonparametric treatment on time covariate and a more precise
estimation on the parametric effect of CD4 counts.
Meanwhile, similar to the study conducted in Chapter 3, it is critical to consider various
data features of repeated measurements, including left-censoring due to a LOD, covariate
measurement error, and asymmetric distribution. A Tobit model is also used to treat the
left-censoring issue more precisely [66, 79]. Recently, models with skew-elliptical distribu-
tions, which include SN and ST distributions (see Section 1.3 in detail), have received much
attention, while the “normality” assumption is violated. We adopt the SN and ST dis-
tributions introduced by Sahu et al. [61] for the parametric covariate measurement error
model.
To the best of our knowledge, little work has been conducted on modeling longitudi-
nal data via PLMM under QR-based framework and simultaneously accounting for LOD,
skewness and covariate measurement error. The main purpose of this chapter is to examine
the heterogeneous relationship between viral load and CD4 cell counts, and the longitu-
dinal trajectory at different quantiles of viral load. Thus, We firstly propose QR-based
PLMM which consists of (i) QR-based PLMM with the ALD [12] considering left censoring
due to LOD, (ii) LME models with skewed distributions for covariate process. A Bayesian
inferential approach is applied to estimate parameters of the joint models as well.
4.2 QR-based partially linear mixed-effects models
4.2.1 CD4 covariate measurement error model with ST distribution
In order to relax the normality assumption and make a robust inference, we assume the co-
variate measurement error model with SE distributions, including SN and ST distributions.
From Section 1.3, we know that the ST distribution, the more general one, is approximate to
the SN distribution when its degrees of freedom increase to infinity. Here we briefly discuss
CD4 covariate measurement error models with an ST distribution. Thus, in the presence
of covariate measurement errors, we consider the following LME model to quantify the
covariate process.
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zij = u
T
ijα+ v
T
ijai + ij (≡ z∗ij + ij),
i
iid∼ STni,ν
(−J(ν)δ1ni , σ21Ini , δIni) , (4.1)
where zi = (zi1, . . . , zini)
T with zij being the observed CD4 covariate value for individual
i at time tij , z
∗
i = (z
∗
i1, . . . , z
∗
ini
)T and z∗ij = u
T
ijα + v
T
ijai is viewed as the true (but
unobservable) covariate at time tij , uij and vij are l × 1 design vectors, α = (α1, . . . , αl)T
and ai = (ai1, . . . , ail)
T are unknown population and individual-specific parameter vectors,
respectively; i = (i1, . . . , ini)
T follows a multivariate ST distribution with three unknown
parameters σ21, δ, ν, representing variance, skewness and degrees of freedom, where the
location parameter is showed as −J(ν)δ1ni with −J(ν) = (ν/pi)1/2[Γ((ν−1)/2)/Γ(ν/2)] in
order to have a zero-mean vector for error term and 1ni = (1, . . . , 1)
T . As the skewness of
overall pooled CD4 measurements are of interest, we specify the skewness matrix being δIni .
We assume that ai
iid∼ Nl(0,Σa) with Σa being unrestricted covariance matrix. We name
model (4.1) as an ST covariate measurement error model accounting for the skewness/heavy
tails in the data.
Specifically, at the absence of theoretical rationale for the CD4 trajectories, we consider
empirical polynomial LME models for the CD4 measurement error model, and choose the
best model based on AIC/BIC values. We consider the CD4 covariate model (4.1) with
uij = vij = (1, tij , . . . , t
l−1
ij )
T and focus on linear (l = 2), quadratic (l = 3) and cubic
(l = 4) polynomials. Among them, we found that the following quadratic polynomial LME
model for the CD4 process has the smallest AIC/BIC values.
zij = (α1 + ai1) + (α2 + ai2)tij + (α3 + ai3)t
2
ij + ij , (4.2)
where z∗ij = (α1 + ai1) + (α2 + ai2)tij + (α3 + ai3)t
2
ij , α = (α1, α2, α3)
T is population (fixed-
effects) parameter vector, ai = (ai1, ai2, ai3)
T is individual-specific (random-effects) vector
with multivariate normal distribution N3(0,Σa), and ij is the measurement error at time
tij following an ST distribution.
40
4.2.2 The QR-based PLMM for viral response
We denote yij as the log10-transformation of the response variable, viral load, for the i
th
subject at time tij (i = 1, 2, ..., n, j = 1, 2, ..., ni). As we discussed previously, due to
the low sensitivity of current standard assays, the measurement of viral load in an HIV
positive individual cannot be quantified accurately when it’s below LOD. To solve the “left-
censoring” issue, the Tobit model is adopted in our joint model framework. Denote the
observed value yij by (qij , cij), where cij is the censoring indicator and qij is the latent
response variable. The latent qij is observed, as yij , then cij = 0, if and only if yij > ζ (a
known constant LOD, log10(40) = 1.602 in our data example). Otherwise, yij is treated as
missing value, and cij = 1.
Certain studies provided some biological arguments for a two-compartment viral dy-
namic model [82,83]. Although such parametric models enjoy simplicity, they have suffered
from inflexibility and misspecification in modeling complicated longitudinal relationships
and trajectories. PLMM, as an intermediate class of model, takes the advantages from
both parametric and non-parametric models. Therefore, to model the comprehensive re-
lationships between viral load and CD4 cell counts accounting for irregular time effects at
different quantiles, a QR-based PLMM is applied to the longitudinal process. Specifically,
the different quantiles of viral load are modeled in terms of a parametric function of the
CD4 counts and a non-parametric function of time:
yi = βiz
∗
i + gi(ti) + ei,
βi = β + bi,
gi(ti) = g(ti) + hi(ti),
(4.3)
where βi is the individual coefficient that quantifies the relationship between viral load
and actual CD4 cell counts for individual i; β is the population coefficient (fixed-effects)
and bi is the random-effects following normal distribution with mean 0 and variance σ
2
b ,
that measures the departure from the population for individual i. Both g(·) and gi(·) are
unknown smoothing functions for population and individual i, respectively. hi(·) represents
the random-effects. The random error ei which follows ALD(0, σ2, τ) whose distribution
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is restricted to have the τth quantile equal to zero with the scale parameter σ2(> 0), i.e.,
Qei(τ |bi; ti, z∗i ) = 0, where Qei(τ |·) ≡ F−1ei (τ |·) is the inverse of cumulative distribution
function (cdf) of ei evaluated at τ with 0 < τ < 1. The error term ei(·) and random
smoothing function gi(·) are zero mean stochastic processes and are independent from each
other; and bi is independent of both ei(·) and gi(·). Note that in model (4.3), we used
the unobserved but actual CD4 counts (z∗i ) instead of the observed value (zi) due to the
CD4 counts measurement error. In this way, the covariate measurement error model (4.1)
is jointly incorporated into the viral response model (4.3).
To fit model (4.3), a regression spline method is applied to g(·) and hi(·) , details can
be found in literature [80, 81]. Briefly, the main idea of regression spline is described as:
g(·) and hi(·) can be approximated by a linear combination of basis functions Ψp(t) =
{ψ0(t), ψ1(t), . . . , ψp−1(t)}T and Φr(t) = {φ0(t), φ1(t), . . . , φr−1(t)}T , respectively. That is,
gp(t) ≈
p−1∑
k=0
ξkψk(t) = Ψp(t)
T ξp,
hi,r(t) ≈
r−1∑
k=0
χkiφk(t) = Φr(t)
Tχri
(4.4)
where ξp = (ξ0, . . . , ξp−1)T is a p × 1 vector of fixed-effects, and χri = (χi0, . . . , χi,r−1)T
(r ≤ p) is a r × 1 vector of random-effects. We assume that χri iid∼ Nk(0,Σχ) with Σχ
being unrestricted covariance matrix. Based on the assumption of hi(·), χri is regarded as
iid realizations of a zero-mean random vector. We consider natural cubic spline bases with
the percentile-based knots in this model. Selection of optimal degree of regression spline
and numbers of knots, in other words, the optimal sizes of p and r, is determined according
to AIC or BIC [80]. In this study, the AIC/BIC values were evaluated for various models
with (p, r) = {(1, 1), (2, 1), (2, 2), (3, 1), (3, 2), (3, 3)}. Among them, we found that the model
with (p, r) = (3, 3) has the smallest AIC/BIC values. Denote Ψ3i = (Ψ3(ti1), . . . ,Ψ3(tini))
T
and Φ3i = (Φ3(ti1), . . . ,Φ3(tini))
T , and plug (4.4) to (4.3). Then, we have the following
QR-based PLMM:
yi = βz
∗
i + biz
∗
i + Ψ3iξ3 + Φ3iχ3i + ei (4.5)
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Let Xi = (z
∗
i ,Ψ3i), Zi = (z
∗
i ,Φ3i), B = (β, ξ
T
3 )
T and $i = (bi,χ
T
3i)
T . We can write
(4.5) as
yi = XiB +Zi$i + ei (4.6)
which is a standard LME model if we assume Xi and Zi are the fixed-effects and random-
effects design matrices, respectively; B and $i are the fixed-effects and random-effects
parameter vectors, respectively, where $i follows N4(0,Σ$) with Σ$ being unrestricted
covariance matrix.
Simultaneous Bayesian inferential approach
In AIDS study, the longitudinal viral load and CD4 cell counts are usually connected phys-
ically or biologically, so joint models are one of the nature ways to statistically investigate
this complex relationship. Although a simultaneous inference method based on a joint
likelihood for the covariate and response data may be favorable, the computational load
in such QR-based joint models with skew distributions can be extremely intensive, even
infeasible, and may lead to convergence problems [69, 73]. Here, we also propose a fully
Bayesian method to estimate parameters in the QR-based PLMM, which consists of models
(4.1) and (4.3). MCMC procedures help us to sample the posterior distribution for each
parameter and make inference simultaneously.
We assume that i, ei, ai and $i are mutually independent of each other. Following
the properties of ST distribution and ALD distribution, it can be shown by introducing the
random vector wi = (wi1, . . . , wini)
T and random variable vij based on the stochastic rep-
resentations in equations (1.12) and (1.5) presented previously, we hierarchically formulate
the joint models (4.1) and (4.6) as follows:
yi|zij ,$i,ai,wi, ui, vij ∼ N (XiB +Zi$i + ϑ1vij , ϑ2σ2vij) ,
zij |ai,wi, ui ∼ Nni
(
z∗ij + δ[wi − J(ν)1ni ], u−1i σ21Ini
)
,
ai ∼ N3 (0,Σa) , $i ∼ N4 (0,Σ$) ,
wi|ui ∼ Nni(0, u−1i Ini)I(wi > 0),
ui|ν ∼ Γ(ν/2, ν/2), vij ∼ Exp(1/σ2),
(4.7)
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where ϑ1 = (1− 2τ)/[τ(1− τ)] and ϑ2 = 2/[τ(1− τ)].
Denote θ = {α,B, σ21, σ2,Σa,Σ$, δ, ν} as the collection of unknown population param-
eters in the joint models (4.1) and (4.6). Under the Bayesian framework, we need to specify
prior distributions for all of these unknown parameters as follows:
α ∼ N3(α0,Ω1), B ∼ N4(β0,Ω2),
σ21 ∼ IG(ω1, ω2), σ2 ∼ IG(ω3, ω4),
Σa ∼ IW (Ω3, ω5), Σ$ ∼ IW (Ω4, ω6),
δ ∼ N(0, ω7), ν ∼ Exp(ν0)I(ν0 > 3)
(4.8)
where the mutually independent Normal (N), Inverse Gamma (IG), Inverse Wishart (IW )
and Exponential (Exp) prior distributions are chosen to facilitate computations. The super-
parameter matrices Ωk (k = 1, . . . , 4) can be assumed to be diagonal for convenient imple-
mentation. The exponential prior for ν is truncated to lie above 3 to make variance of ST
distribution well-defined.
Let f(·), f(·|·), F (·|·) and pi(·) denote a density function, a conditional density func-
tion, a cumulative density function (c.d.f) and a prior density function, respectively. Since
α,B, σ21, σ2,Σa,Σ$, δ, and ν are assumed to be independent of each other, we have
pi(θ) = pi(α)pi(B)pi(σ21)pi(σ2)pi(Σa)pi(Σ$)pi(δ)pi(ν). Subsequently, after specifying the joint
models for the observed data and the prior distributions for the unknown parameters, we can
make Bayesian inference for the parameters based on their posterior distributions. Thus, the
joint posterior density of θ based on the observed data D = {(qij , cij , zij), i = 1, . . . , n; j =
1, . . . , ni} can be given by
f(θ|D) ∝ {
n∏
i=1
∫ ∫ ni∏
j=1
f(yij |zij ,$i,ai,wi, ui, vij)1−cijF (ζ|zij ,$i,ai,wi, ui, vij)cij
f(zij |ai,wi, ui)f(wi|ui,wi > 0)f(ui)f($i)f(ai)f(vij)d$idai}pi(θ).
(4.9)
With the joint posterior density, Bayesian inference can be implemented by WinBUGS
software [87] interacted with bugs function in R package R2WinBUGS.
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4.4 Application to MACS data
4.4.1 Model implementation
The MACS data also motivated this study. The QR-based PLMM in Section 2, which
specifies a quadratic polynomial LME model (4.2) for CD4 process, and a partially LME
model (4.6) for the longitudinal viral load process, appears to provide an appropriate fit
to the observed data. As shown in Figure 3(b) previously, the histogram of CD4 cell
counts clearly indicates its asymmetric feature. Thus, it is plausible to consider the skewed
distribution, such as SN and ST distribution in the covariate measurement error model.
Besides LOD, although the outcome variable viral load also exhibits skewness and outliers,
we specify ALD instead of the SN or ST distribution in order to construct a QR-based model,
which is robust to these data features. With this information, the following three statistical
models with specifying different distributions based on the joint models are employed to
compare their performance:
• Model ST: eij and ij follow ALD and ST distribution, respectively.
• Model SN: eij and ij follow ALD and SN distribution, respectively.
• Model N: eij and ij follow ALD and normal distribution, respectively.
Since a normal distribution is a special case of an SN distribution when skewness param-
eter is zero and is commonly used in other studies, we investigate how the covariate model
(4.1) using an asymmetric (SN or ST) distribution in joint models contributes to model-
ing results and parameter estimation in comparison with that using a symmetric (normal)
distribution.
To perform the Bayesian inference process, we need to specify the values for the hyper-
parameters in the prior distributions (4.8). We take weakly informative prior distributions
for the parameters in the joint models. In particular, (i) fixed-effects are taken to be inde-
pendent normal distribution N(0, 100) for each element of the population parameter vectors
α, andB; (ii) we assume a noninformative inverse Gamma prior distribution IG(0.01, 0.01),
which has mean 1 and variance 100, for scale parameter σ21 and σ2 ; (iii) the priors for the
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variance-covariance matrices of the random-effects Σa and Σ$ are taken to be inverse
Wishart distributions IW (diag(0.01, 0.01, 0.01), 3) and IW (diag(0.01, 0.01, 0.01, 0.01), 4);
(iv) for the skewness parameter δ, a normal distributions N(0, 100) is chosen; (v) the degree
of freedom parameter ν follows truncated exponential distribution with ν0 = 0.5.
The MCMC sampler was implemented using WinBUGS software [87] interacted with
R2WinBUGS of R software, and the program code is available in Appendix B. Convergence
of the generated samples was assessed using standard tools within WinBUGS software such
as trace plots and GR diagnostics [88]. Figure 6 shows the trace plots, autocorrelation
and dynamic version of GR diagnostic plots based on Model ST for the representative
parameters β, α1, δ, and ν. All of these plots implies that convergence is ensured.
beta[1] chains 3:1
iteration
195019001850
-1.0
-0.8
-0.6
-0.4
-0.2
beta[1] chains 1:3
lag
0 20 40
-1.0
-0.5
0.0
0.5
1.0
beta[1] chains 1:3
iteration
1001 1500
0.0
0.5
1.0
alpha[1] chains 3:1
iteration
195019001850
0.4
0.5
0.6
0.7
0.8
alpha[1] chains 1:3
lag
0 20 40
-1.0
-0.5
0.0
0.5
1.0
alpha[1] chains 1:3
iteration
1001 1500
0.0
0.5
1.0
1.5
delta chains 3:1
iteration
195019001850
0.45
0.5
0.55
0.6
delta chains 1:3
lag
0 20 40
-1.0
-0.5
0.0
0.5
1.0
delta chains 1:3
iteration
1001 1500
0.0
0.5
1.0
1.5
nu chains 3:1
iteration
195019001850
3.0
3.5
4.0
4.5
5.0
nu chains 1:3
lag
0 20 40
-1.0
-0.5
0.0
0.5
1.0
nu chains 1:3
iteration
1001 1500
0.0
0.5
1.0
1.5
Figure 6: Convergence diagnostics for representative parameters based on QR-based PLMM
(Model ST) with τ = 0.5: trace plots (left panel); Autocorrelation plots (middle panel);
Gelman-Rubin (GR) diagnostic plots (right panel)
When these criteria suggested the convergence of chains, we proposed that, after an
initial number of 50,000 burn-in iterations of three chains of length 100,000, every 50th
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MCMC sample was retained from the next 50,000 for each chain. Thus, we obtained a
total of 3,000 samples of targeted posterior distributions of the unknown parameters for
statistical inference. The Bayesian modeling approach in conjunction with the joint models
with different scenarios is applied to fit the MACS data for inference. The computational
burden for fitting such complicated joint models is intensive. In this case, to fit Model ST
with quantile τ = 0.5, it took about 18 h on a Windows PC with Intel Core i7-6700 CPU
@ 3.40 GHz and RAM of 16 GB. In the following section, we report the results based on
these 3 scenarios highlighted above.
4.4.2 MACS data analysis results
Bayesian joint modeling approach in conjunction with the joint models at the five quantiles
of τ = 0.05, 0.25, 0.50, 0.75 and 0.95 was applied to fit the longitudinal viral load and CD4
data jointly. Table 4 presents the population posterior mean, the corresponding 95% CI for
fixed-effects parameters based on the three proposed models (ST, SN and N). The following
findings are obtained for the results of estimated parameters.
For all Models ST, SN and N with the five quantiles of τ = 0.05, 0.25, 0.50, 0.75 and
0.95, firstly, it is interesting that the estimates of the key parameter β, that quantifies
the effect of CD4 cell counts on viral load, are all significant but with different negative
values. The results suggest a varying negative relationship between viral load and CD4
counts in the population level at different quantiles, while the estimated values of β reveal
a “flat arch” shape (Figure 7(a)). Under the same models, the estimated value of β is the
largest at median (τ = 0.50), and decrease as quantile goes extremely (in both directions)
with the smallest value at τ = 0.95. Second, in comparison of Models ST, SN and N at
the same quantile of τ , the values of estimated β at different quantiles in Model ST are
smaller than their counterparts in Models SN and N, whereas those in Model N are the
largest. This finding may indicate an underestimated negative CD4 effect by employing a
joint model in which covariate model errors follow normal or SN distribution. Third, for the
parameters in the nonparametric part of PLMM, as τ increases, the estimates of ξ1 increase;
from low quantiles to the median, the estimates of ξ2 increase; reversely, from the median
to high quantiles, the estimates of ξ2 decrease. Fourth, from the population estimating
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Table 4: Summary of estimated posterior mean (PM) of population (fixed-effects) parame-
ters, the corresponding lower limit (LCI) and upper limit (UCI) of 95% equal-tail credible
interval (CI) as well as DIC values for QR-based PLMM.
Method Model β ξ1 ξ2 ξ3 α1 α2 α3 σ
2
1 σ2 δ ν DIC
τ = 0.05
JM ST PM -0.57 -25.23 4.37 -9.31 0.58 -5.97 7.40 0.05 1.24 0.53 3.67 69720.1
LCI -0.86 -25.54 -14.76 -28.01 0.50 -6.75 6.17 0.04 1.21 0.49 3.13
UCI -0.23 -24.88 24.55 10.76 0.67 -5.25 8.82 0.06 1.27 0.56 4.35
JM SN PM -0.55 -25.20 4.48 -9.39 0.59 -6.24 7.83 0.07 1.24 0.73 – 73963.5
LCI -0.87 -25.54 -14.47 -28.53 0.51 -7.13 6.49 0.06 1.21 0.69 –
UCI -0.25 -24.87 23.38 9.90 0.68 -5.42 9.16 0.08 1.27 0.76 –
JM N PM -0.48 -25.22 4.29 -8.89 0.69 -7.35 9.65 0.26 1.24 – – 76812.4
LCI -0.82 -25.55 -15.11 -28.62 0.60 -8.21 8.20 0.25 1.21 – –
UCI -0.12 -24.88 23.41 10.60 0.78 -6.50 11.17 0.27 1.27 – –
τ = 0.25
JM ST PM -0.51 -2.10 15.63 -27.91 0.56 -5.76 7.17 0.05 1.47 0.53 3.69 57159.5
LCI -0.67 -2.27 -3.64 -46.80 0.48 -6.45 5.80 0.04 1.43 0.49 3.11
UCI -0.35 -1.89 35.45 -9.62 0.65 -4.99 8.37 0.06 1.51 0.56 4.37
JM SN PM -0.50 -2.07 15.88 -27.82 0.59 -6.21 7.82 0.07 1.47 0.73 – 61334.1
LCI -0.67 -2.26 -3.30 -46.80 0.51 -7.02 6.62 0.06 1.43 0.70 –
UCI -0.34 -1.84 35.29 -8.44 0.68 -5.48 9.33 0.08 1.51 0.76 –
JM N PM -0.44 -2.08 15.63 -27.61 0.68 -7.24 9.44 0.26 1.47 – – 64326.9
LCI -0.64 -2.26 -4.33 -46.31 0.59 -8.15 8.01 0.25 1.43 – –
UCI -0.25 -1.89 35.08 -8.77 0.78 -6.43 11.05 0.27 1.51 – –
τ = 0.50
JM ST PM -0.50 2.89 16.93 -20.38 0.58 -5.92 7.40 0.05 1.55 0.53 3.68 53656.5
LCI -0.62 2.51 -3.20 -47.83 0.48 -6.60 5.98 0.04 1.50 0.49 3.12
UCI -0.28 3.18 36.81 3.25 0.66 -5.08 8.58 0.06 1.59 0.56 4.36
JM SN PM -0.48 2.74 19.05 -29.05 0.59 -6.22 7.83 0.07 1.55 0.73 – 57810.9
LCI -0.63 2.49 -0.56 -51.59 0.51 -6.94 6.53 0.06 1.51 0.70 –
UCI -0.31 3.10 39.51 -2.13 0.68 -5.43 9.06 0.08 1.60 0.76 –
JM N PM -0.45 2.66 19.48 -32.31 0.69 -7.34 9.62 0.26 1.56 – – 60778.4
LCI -0.62 2.49 0.79 -50.81 0.59 -8.30 7.88 0.25 1.51 – –
UCI -0.27 2.84 38.84 -12.92 0.79 -6.39 11.36 0.27 1.60 – –
τ = 0.75
JM ST PM -0.54 7.20 16.14 -29.30 0.58 -5.93 7.41 0.05 1.49 0.53 3.69 56738.8
LCI -0.69 7.05 -3.48 -47.76 0.50 -6.70 6.16 0.04 1.46 0.49 3.14
UCI -0.37 7.40 35.72 -10.74 0.66 -5.20 8.74 0.06 1.54 0.56 4.36
JM SN PM -0.53 7.21 16.04 -29.04 0.59 -6.15 7.71 0.07 1.50 0.73 – 60940.7
LCI -0.69 7.03 -2.77 -47.79 0.50 -6.86 6.28 0.06 1.45 0.70 –
UCI -0.37 7.40 35.57 -9.94 0.67 -5.31 8.83 0.08 1.54 0.76 –
JM N PM -0.49 7.22 15.67 -28.61 0.68 -7.20 9.37 0.26 1.50 – – 63888.3
LCI -0.68 7.04 -3.18 -47.85 0.58 -8.09 7.83 0.25 1.46 – –
UCI -0.31 7.40 35.06 -9.55 0.78 -6.26 11.00 0.27 1.54 – –
τ = 0.95
JM ST PM -0.66 29.41 4.48 -9.47 0.58 -5.99 7.49 0.05 1.26 0.53 3.17 69516.4
LCI -0.96 29.10 -14.82 -29.51 0.50 -6.57 6.35 0.04 1.23 0.49 3.10
UCI -0.33 29.75 23.70 10.27 0.66 -5.38 8.46 0.06 1.30 0.56 4.33
JM SN PM -0.64 29.43 4.35 -9.24 0.59 -6.20 7.76 0.07 1.26 0.73 – 73762.3
LCI -0.95 29.10 -15.24 -29.54 0.50 -7.04 5.99 0.06 1.23 0.70 –
UCI -0.33 29.78 24.59 9.84 0.69 -5.22 9.20 0.08 1.30 0.76 –
JM N PM -0.60 29.44 4.64 -9.33 0.69 -7.31 9.55 0.26 1.26 – – 76656.3
LCI -0.95 29.11 -15.11 -28.86 0.59 -8.15 7.87 0.25 1.23 – –
UCI -0.24 29.77 24.48 9.88 0.78 -6.29 11.09 0.27 1.30 – –
nonparametric function g(t) at five different quantiles (Figure 7(b)-(f)), it is seen that,
generally, g(t) decreases initially and then rebounds, but the decrease and rebound rates
48
are smaller when τ = 0.05 and 0.95, compared to those at other quantiles. Though there
are slight deviations among the estimated g(t) curves of different models, the estimates of
parameters in the nonparametric part are comparable, except those at τ = 0.50.
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Figure 7: The population-level estimated result: (a) Strength of the correlation between
viral load and CD4 counts under different scenarios; (b)-(f) The population estimating
curves of g(t) based on the three models at five different quantiles, respectively.
In general, the estimated results for the parameters in the covariate model (4.2) at the
five quantiles are comparable. The estimates of the linear coefficient α2 are significantly
negative, whereas the estimates of α1 and α3 are significantly positive. This finding suggests
that there is a negative linear relationship between CD4 cell counts and measurement time.
In comparison of Models ST, SN and N at the same quantile of τ , the estimated α1 and
α3 in Model N are larger than their counterparts in Model ST and SN, while the estimated
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α2 in Model N are smaller than their counterparts in Model ST and SN. However, the
estimates of α1 in Model ST and SN are comparable, the estimated α2 and α3 vary slightly.
Furthermore, it is noted that the estimated skewness parameter δ has a significantly positive
value in Models SN and ST. This finding suggests that there is a significantly positive
skewness on the CD4 data and confirms the fact that the distribution of the original CD4
data is right-skewed. Thus, incorporating a skewness parameter in the modeling of the CD4
covariate data is highly recommended. Interestingly, the estimated δ in Model ST is smaller
than that in Model SN. It could be explained by adding one more parameter, degrees of
freedom ν, in Model ST, which is significantly positive. Also, due to the consideration of
skewness in both Models SN and ST, it is no surprising to see the great reduction for the
estimates of scale parameter σ21.
In order to compare models under different settings, the DIC values obtained are also
summarized in Table 4. It is seen that the DIC values in Model ST are smaller than their
counterparts in Models SN and N at the same quantile of τ . Within any one of these three
models, the DIC value is the smallest at the quantile of τ = 0.50, whereas the DIC value
is the largest at the quantile of τ = 0.05. This may suggest that the smaller amount of
information is available at more extreme quantiles (e.g. τ = 0.05 or τ = 0.95). Therefore,
according to the DIC, the ST model-based median regression (τ = 0.50) is the best fitting
model, because of the smallest DIC (53656.5). In summary, our results suggest that it is
important to assume an ST distribution for the covariate model in order to achieve more
reliable results, particularly when the CD4 data exhibits non-normality.
For a specific application, we further report findings based on the best fitted model,
Model ST in detail. First, the estimates of β vary from -0.50 with 95%CI: (-0.62, -0.28)
at τ = 0.50 to -0.66 with 95%CI: (-0.96, -0.33) at τ = 0.95. In detail, as CD4 cell counts
(standardized) increase one unit, the median of viral load (log10 transformed) will decrease
by 0.5, but the 95th quantile will decrease by 0.66 at a given time, and both of these
negative associations are statistically significant. Interestingly, a quadratic relationship is
found between estimated values of β and different quantiles: β = −0.60 + 0.50τ − 0.60τ2.
This finding indicates that for the AIDS patients with high-level viral load, the effect of
CD4 counts is stronger than other patients. In other words, the HIV treatment ART may
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be more effective among severe AIDS patients. Additionally, the absolute value of the
estimated β at τ = 0.05 is also relatively high (β = −0.57, 95%CI : [−0.86,−0.23]), which
could be partially explained by the fact that in the early stages of HIV, patients may be
more sensitive to the drugs. Second, when τ = 0.50, the estimated results indicate that
the population CD4 trajectory may be approximated by the quadratic polynomial LME
model: zˆ∗(t) = 325.01(0.58 − 5.92t + 7.40t2) + 556.25, where zˆ∗(t) is in the original CD4
scale. The population viral load process may be approximated by the PLMM: Vˆ (t) =
−0.50zˆ∗(t) + 2.89ψ0(t) + 16.93ψ1(t) − 20.38ψ2(t). Remind that this simple approximation
considered here may provide a rough guidance and point to further research even though
the true association described above may be complicated. The above findings may not be
revealed from traditional mean regression models.
4.5 Simulation studies
To evaluate performance of our proposed QR-based PLMM and method, we conducted
the following simulation studies. The design of the simulated data is similar to the real
data used for the joint models. Specifically, we adopted the sample size with n =300, and
assumed that each subject had 23 scheduled longitudinal measurements. The measurement
time points generated in the simulation are mimicked those in the real data analysis, and
the true parameter values are selected as follows: β = −5, ξ3 = (ξ1, ξ2, ξ3)T = (10, 10, 10)T ,
α = (α1, α2, α3)
T = (−5,−6,−10)T , $i ∼ N(0, diag(1, 1, 1, 1)). The time-varying CD4
covariate zij is generated based on equation (4.2) with (ai1, ai2, ai3)
T ∼ N(0, diag(1, 1, 1));
we simulated the model errors eij and ij from a Γ(2, 1) distribution, then subtracted by 2,
which yields a skewed distribution with the mean 0 and variance 2. To simulate LOD data,
we selected the 15% quantile of the longitudinal response as a cut-of threshold so that 15%
of the data are below LOD. According to the settings described above, we generated 50 data
sets due to intensive computation, and fitted the data by Models N, SN and ST at three
different quantiles of τ = 0.25, 0.50 and 0.75. Note that the prior distributions considered are
all close to non-informative as they were treated in real data analysis. Therefore, we expect
the results to be somewhat robust with respect to prior distributions. Table 5 summarizes
the simulation results which include the true parameter values, percent bias (defined by
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100×biasl/|TPl|) and percent MSE (defined by 100×
√
MSEl/|TPl|) of fixed-effects β, ξ3,
and α.
Table 5: Summary of true parameter (TP) values, estimated parameters, bias and MSE for
Models N, SN and ST based on 100 simulated data sets
TP Model N Model SN Model ST
τ = 0.25 τ = 0.50 τ = 0.75 τ = 0.25 τ = 0.50 τ = 0.75 τ = 0.25 τ = 0.50 τ = 0.75
β = −5 EST -5.14 -5.14 -3.38 -5.12 -5.13 -3.38 -5.12 -5.12 -3.40
Bias -2.74 -2.79 32.29 -2.50 -2.63 32.45 -2.32 -2.43 31.92
MSE 2.85 3.08 32.33 2.72 2.80 32.53 2.46 2.68 31.99
ξ1 = 10 EST 3.42 10.60 43.17 3.47 10.58 42.90 3.55 10.42 42.81
Bias -65.83 6.04 331.66 -65.27 5.85 329.03 -64.48 4.23 328.13
MSE 65.88 6.36 331.79 65.31 6.53 329.17 64.84 4.86 328.31
ξ2 = 10 EST 10.05 10.07 9.68 10.02 10.06 9.69 10.02 10.05 9.69
Bias 0.54 0.71 -3.18 0.16 0.60 -3.13 0.21 0.55 -3.09
MSE 0.79 1.06 3.21 0.35 0.74 3.18 0.72 0.80 3.14
ξ3 = 10 EST 9.92 9.85 9.44 9.94 9.85 9.44 9.95 9.87 9.45
Bias -0.80 -1.46 -5.57 -0.56 -1.49 -5.63 -0.46 -1.40 -5.55
MSE 0.93 1.56 5.60 0.81 1.57 5.66 0.81 1.45 5.60
α1 = −5 EST -4.93 -5.31 -5.65 -4.79 -5.29 -5.72 -4.97 -5.16 -5.30
Bias 1.30 -6.12 -12.96 4.14 -5.73 -14.43 0.56 -3.19 -6.00
MSE 2.01 6.42 13.09 4.41 5.97 14.54 1.10 3.50 6.07
α2 = −6 EST -5.70 -5.66 -5.74 -5.74 -5.74 -5.76 -5.98 -5.74 -5.90
Bias 4.95 5.63 4.26 4.38 4.34 3.99 0.40 4.23 1.68
MSE 5.05 5.71 4.33 4.55 4.48 4.01 1.04 4.31 1.92
α3 = −10 EST -10.13 -10.19 -10.16 -10.09 -10.19 -10.27 -10.04 -10.02 -10.13
Bias -1.25 -1.93 -1.55 -0.94 -1.93 -2.71 -0.43 -0.18 -1.27
MSE 1.35 2.04 1.62 1.34 2.18 2.88 0.62 0.75 2.20
For all scenarios considered in this simulation study, it is of interest to see that the
estimated biases of parameter β in the parametric part of PLMM are negative when τ = 0.25
and 0.50, and positive when τ = 0.75. The differences among the estimated β at different τ
confirm that QR-based models can be used to detect the heterogeneous effects of covariate
at different quantiles of the outcome. In the nonparametric part, the magnitude of ξ1
increases as τ becomes larger. The big bias of this intercept parameter at τ = 0.25 and
0.75 is understandable in QR-based model, which is in consistent to the results of real
data analysis. Besides, the sign of the bias suggests that ξ2 appears overestimated except
when τ = 0.75, and ξ3 seems to be underestimated with the increasing bias as τ increases.
Additionally, in comparison of Models ST, SN and N at the same quantile of τ , Model ST
outperforms Models SN and N in terms of smaller bias and MSE, excluding ξ2 at τ = 0.25
(in this scenario, Model SN seems to be the best). For parameters in covariate model, it
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can be observed that Model ST performs obviously better than Models N and SN because
of the smaller bias and MSE. Specifically, bias of α ranges from −6.00% to 4.23% in Model
ST, while bias ranges from −12.96% to 5.63% and from −14.43% to 4.38% in Models N and
SN, respectively. In summary, the simulation study suggests that it is critical to account
for skewness/heavy tails exhibited in the covariate by assuming an ST distribution.
4.6 Concluding discussion
To comprehensively study the complicated relationship between viral load and CD4 cell
counts and the complex viral load trajectories at both population and individual levels,
we presented a QR-based PLMM in this chapter, which is a special case of QR-based
semiparametric models. We also considered some important data features which may affect
the discovery of the longitudinal process, including CD4 covariate measurement errors,
skewness, and viral load below LOD. This is the first time of jointly modelling QR-based
PLMM, and covariate measurement error model, accounting for multiple longitudinal data
features simultaneously.
The proposed QR-based PLMM has many advantages compared to traditional mean-
regression models, and pure parametric or nonparametric models. First, the parametric
part of our QR-based PLMM detected the varying strength of CD4 effect on viral load
at different quantiles, which gives researchers and physicians a full understanding of this
significantly negative relationship. Specifically, the strongest negative effect was found at
quantile τ = 0.95, indicating that the effect of CD4 counts is more important among patients
with higher viral load, which is in consistent with biological mechanism. In other words, it
may suggest that ART is more effective for those patients with higher risk. Interestingly,
the results also showed that the CD4 effect is relatively stronger at lower quantile τ = 0.05.
In this circumstance, the result suggests that, once the disease is discovered (when the viral
load level of patients is low), the infected patients should be treated as soon as possible,
because these patients may be more sensitive to the treatment in early stages of treatment.
These findings may be undetectable via traditional mean-regression models. Second, the
nonparametric part of our models has the flexibility to model the viral dynamics by avoiding
parametric misspecification, in order to monitor disease process accurately. More than that,
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it is pretty useful to observe the heterogeneous viral load trajectories at different quantiles.
Compared to mean-regression models, it is more precise for physicians to evaluate treatment
and make clinical decisions in accordance with the idea of “precision medicine”.
As one of the most important sources to clear out HIV virus, it is important to consider
CD4 cell counts measurement error appropriately when it exhibits skewness and heavy tails.
This study considered three models (Models N, SN and ST) with different scenarios, and
found that Model ST is favorable in general to other two models. For the covariate model
with ST distribution, the estimates of skewness parameter δ and the degrees of freedom
ν are around 0.53 and 3.68, respectively, indicating positive skewness with heavy tail of
the CD4 cell counts. Compared to Model SN, the magnitude of estimated δ is smaller in
Model ST. This may be explained by the fact that the additional parameter ν for heaviness
in the tails of ST distribution reduced the effect of skewness. The simulation studies also
confirmed the results of real data analysis that Model ST gains more efficiency and accuracy
in parameter estimation when covariate is in presence of skewness and heavy tails.
In Bayesian analysis, sensitivity analysis is important to check the changes of the poste-
rior estimates when assuming different priors. Towards to the end, we performed sensitivity
analysis by adopting a few sets of different values for the hyper-parameters in (4.8) and
re-run the MCMC sampling procedure. The similar results give us confidence that the
posterior estimates are robust to the hyper-parameter values. Moreover, the lower order
polynomial model (4.2), that we applied to approximate the CD4 covariate process, is em-
pirical and may not be true for the unknown CD4 path. Thus, the fitted CD4 counts based
on this model are “regularized” CD4 counts instead of the “true” values. It provides a way
to alleviate measurement errors in observed CD4 counts.
In conclusion, in this chapter we proposed a new flexible joint models, QR-based PLMM,
with advances in HIV/AIDS dynamics to fully quantify complicated HIV disease mechanism.
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Chapter 5 QR-based partially linear mixed-effects joint
models for longitudinal and time-to-event data with multiple
features
5.1 Introduction
In many longitudinal studies, in addition to the repeatedly measured markers, time-to-
event outcome is also recorded. The relationship between a time-to-event outcome and
a longitudinal marker is often of interest. For example, in HIV/AIDS studies, the viral
load drops down and CD4 cell counts picks up dramatically for most of the patients at
the early stage of treatment; but as the treatment continues, rebound of the viral load and
suppression of CD4 cell counts appear on some patients [94]. As we known, the increase of
viral load and the reduction of CD4 cell counts lead to severe immunological deficiency, and
the changes of them are critical indicators of HIV disease progression and prognosis [82,84].
Thus, longitudinal dynamics of viral load and CD4 cell counts, which is more important
than an individual test result, as well as other risk factors, may be predictive of the risk of
death.
Joint analysis of longitudinal and time-to-event data is active research area of bio-
statistics, since separate inferences, like the two-stage (TS) model, may lead to biased or
inefficient results [73–77]. Besides, due to the robustness and comprehensiveness, QR has
been extended to complicated joint models in AIDS research. For example, Farcomeni and
Viviani [35] developed QR-based longitudinal-survival joint models in the presence of in-
formative dropout; Huang et al. proposed QR-based nonlinear mixed-effects joint models
for longitudinal and time-to-event data [41]. Also, in Chapter 3, we presented QR-based
nonlinear mixed-effects joint models for longitudinal-survival data with multiple data fea-
tures. These QR-related works complement and improve the traditional mean regression
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based joint models.
In Chapter 4, we proposed a QR-based PLMM, which is a special case of semiparametric
model. It is more flexible than parametric models, and is more parsimonious than nonpara-
metric models. Specifically, to avoid the possible misspecification issue, a nonparametric
function of time is more appropriate; and to precisely measure and better interpret the CD4
effects, a parametric function is adopted. Due to these benefits, it is reasonable to extent
our QR-based PLMM for longitudinal data to QR-based partially linear mixed-effects joint
models (PLMJM) for longitudinal-survival data.
To the best of our knowledge, little work has been conducted on modeling longitudinal
and time-to-event data via PLMJM under QR-based framework, and accounting for multiple
data features, including LOD, covariate measurement error, and skewness simultaneously.
Thus, in this chapter, we propose a QR-based PLMJM consisting of (i) QR-based PLMM
using the ALD [12] for the longitudinal response process, (ii) LME models with skewed
distributions for covariate process, and (iii) Cox proportional hazard model for time-to-
event process, which is linked to longitudinal response and covariate processes through
random-effects. A Bayesian inferential approach is also used.
5.2 QR-based partially linear mixed-effects joint models
5.2.1 CD4 covariate measurement error model with ST distribution
As a straightforward extension of the joint models we proposed in Chapter 4, we consider
the same LME model with an ST distribution to quantify the covariate process.
zij = u
T
ijα+ v
T
ijai + ij (≡ z∗ij + ij),
i
iid∼ STni,ν
(−J(ν)δ1ni , σ21Ini , δIni) , (5.1)
where zi = (zi1, . . . , zini)
T with zij being the observed CD4 cell counts for individual i at
time tij , z
∗
i = (z
∗
i1, . . . , z
∗
ini
)T and z∗ij = u
T
ijα+v
T
ijai represents the true (but unobservable)
CD4 covariate value at time tij . Details of the model could be find in Section 4.2.1.
Specifically, the following quadratic polynomial LME model is selected as the “best”
model for the CD4 process, because of the smallest AIC/BIC values.
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zij = (α1 + ai1) + (α2 + ai2)tij + (α3 + ai3)t
2
ij + ij , (5.2)
where z∗ij = (α1 + ai1) + (α2 + ai2)tij + (α3 + ai3)t
2
ij , α = (α1, α2, α3)
T is population
(fixed-effects) parameter vector, ai = (ai1, ai2, ai3)
T is individual-specific (random-effects)
vector with multivariate normal distribution N3(0,Σa), and ij is the error term at time tij
following an ST distribution.
5.2.2 The QR-based PLMM for viral response
Here, the QR-based PLMM is also as same as that presented in Section 4.2.2. Generally,
We denote yij as the log10-transformation of the viral load for the i
th subject at time tij
(i = 1, 2, ..., n, j = 1, 2, ..., ni). Due to the LOD, we offer the Tobit model in our joint
models framework. We denote the observed value yij by (qij , cij), where cij is the censoring
indicator and qij is the latent response variable. The latent qij is observed, as yij , then
cij = 0, if and only if yij > ζ (a known constant LOD, log10(40) = 1.602 in MACS data).
Otherwise, yij is treated as missing value, and cij = 1. Then the QR-based PLMM is
specified with a parametric function of the CD4 counts and a non-parametric function of
time.
yi = βiz
∗
i + gi(ti) + ei,
βi = β + bi,
gi(ti) = g(ti) + hi(ti),
(5.3)
where βi is the individual coefficient that quantifies the relationship between viral load and
actual CD4 cell counts for individual i; β is the population coefficient (fixed-effects); bi is the
random-effects following normal distribution with mean 0 and variance σ2b , that measures the
departure from the population for individual i. Both g(·) and gi(·) are unknown smoothing
functions for population and individual i, respectively. hi(·) represents the random-effects.
The random error ei which follows ALD(0, σ2, τ) whose distribution is restricted to have the
τth quantile equal to zero with the scale parameter σ2(> 0), i.e., Qei(τ |bi; ti, z∗i ) = 0, where
Qei(τ |·) ≡ F−1ei (τ |·) is the inverse of cumulative distribution function (cdf) of ei evaluated
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at τ with 0 < τ < 1. The error term ei(·) and random smoothing function gi(·) are zero
mean stochastic processes and are independent from each other; and bi is independent of
both ei(·) and gi(·). Note that in model (5.3), we used z∗i , the unobserved but actual CD4
counts instead of zi, the observed value. In this way, the covariate measurement error model
(5.1) is jointly incorporated into the viral response model (5.3).
The parametric part of model (5.3) is straightforward, which is a LME model. To fit
the nonparametric part, a regression spline method is applied to g(·) and hi(·) , details
can be found in Section 4.2.2. Briefly, the key idea of regression spline is described as:
g(·) and hi(·) can be approximated by a linear combination of basis functions Ψp(t) =
{ψ0(t), ψ1(t), . . . , ψp−1(t)}T and Φr(t) = {φ0(t), φ1(t), . . . , φr−1(t)}T , respectively. That is,
gp(t) ≈
p−1∑
k=0
ξkψk(t) = Ψp(t)
T ξp,
hi,r(t) ≈
r−1∑
k=0
χkiφk(t) = Φr(t)
Tχri
(5.4)
where ξp = (ξ0, . . . , ξp−1)T is a p × 1 vector of fixed-effects, and χri = (χi0, . . . , χi,r−1)T
(r ≤ p) is a r×1 vector of random-effects. We assume that χri iid∼ Nk(0,Σχ) with Σχ being
unrestricted covariance matrix. Based on the assumption of hi(·), χri is regarded as iid
realizations of a zero-mean random vector. We consider natural cubic spline bases with the
percentile-based knots in this model. The optimal degree of regression spline p and numbers
of knots r are determined according to AIC/BIC values, which is (p, r) = (3, 3). After
denoting Ψ3i = (Ψ3(ti1), . . . ,Ψ3(tini))
T and Φ3i = (Φ3(ti1), . . . ,Φ3(tini))
T , and pluging
(5.4) to (5.3), we have the following QR-based PLMM:
yi = βz
∗
i + biz
∗
i + Ψ3iξ3 + Φ3iχ3i + ei (5.5)
Let Xi = (z
∗
i ,Ψ3i), Zi = (z
∗
i ,Φ3i), B = (β, ξ
T
3 )
T and $i = (bi,χ
T
3i)
T . We can write
(5.5) as
yi = XiB +Zi$i + ei (5.6)
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which looks like a standard LME model if we assume Xi and Zi are the fixed-effects and
random-effects design matrices, respectively; B and $i are the fixed-effects and random-
effects parameter vectors, respectively, where $i follows N4(0,Σ$) with Σ$ being unre-
stricted covariance matrix.
5.2.3 Cox proportional hazard model for time-to-event data
The Cox proportional hazard model has been widely used to investigate the effects of co-
variates upon the time a specified event takes to happen. We assume that the distribution
of Ti, the death time for the i
th subject, depends on the random-effects bi and ai, rep-
resenting individual-specific longitudinal processes for response and covariate, and other
risk factors xi, respectively. Thus, a frailty model is considered for Ti, which is linked to
QR-based PLMM model (5.3) and covariate measurement error model (5.1) through the
random-effects bi and ai, respectively. Additional covariates xi are assumed to be associ-
ated with the event time but not with the longitudinal measurements. Specifically, for the
survival component, the conditional hazard rate of Ti at time ti is expressed as
λ(ti|bi,ai,xi) = λ0(ti) exp(γT1 bi + γT2 ai + γT3 xi) = λ0(ti) exp(γTdi), (5.7)
where λ0(ti) is the baseline hazard function, di = (b
T
i ,a
T
i ,x
T
i )
T , γ = (γT1 ,γ
T
2 ,γ
T
3 )
T , γ1, γ2
and γ3 are unknown parameters linking the random-effects bi, ai and covariates xi to the
conditional hazard rate, respectively.
Let ρi = (ρi1, . . . , ρini)
T be a vector of censoring indicator for individual i: ρij = 1 if the
patient has died by time tij , otherwise, ρij = 0. We assume that ρi1 = 0 for all subjects. The
contribution to the likelihood from the time-to-event model for the ith subject is denoted
by f(ρi|di). Thus, we have
f(ρi|di) =
∏ni
j=1 f(ρij |ρij∗ , 0 ≤ j∗ < j;di), (5.8)
where f(ρij |ρij∗ , 0 ≤ j∗ < j;di) = pρijij (1 − pij)1−ρij and ρij equals to 0 before death and
1 after death. The counting process is also applied to approximate the Cox proportional
hazard model (see Section 3.2.3 for details). It may reduce some computing load and
simplify the presentation.
Specifically, to avoid extremely heavy computational load, we only put random-effects
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bi1 and ai2 into the model, as well as other risk factors. Other covariates of interest include
age of seroconversion (agei), and race (racei), with racei = 1 if subject i is white, and
racei = 0 otherwise. Therefore, the Cox regression model (5.7) is specified as
λ(ti|bi,ai,xi) = λ0(ti) exp(γ1bi + γ2ai2 + γ3agei + γ4racei), (5.9)
where γ = (γ1, . . . , γ4)
T is the parameters corresponding to the random-effects (bi1, ai2),
covariates (agei, racei).
5.3 Simultaneous Bayesian inferential approach
Similar to what we discussed in Chapter 3 and 4, Bayesian method shows the advantage on
the inferential process of such complicated joint models. Thus, we simultaneously estimate
parameters for the QR-based PLMJM under a fully Bayesian framework.
We assume that i, ei, ai and $i are mutually independent of each other. Following
the properties of ST distribution and ALD distribution, it can be shown by introducing
the random vector wi = (wi1, . . . , wini)
T and random variable vij based on the stochastic
representations in equations (1.12) and (1.5), we hierarchically formulate the joint models,
which consists of covariate measurement error model (5.1), QR-based PLMM (5.6), and
Cox proportional hazard model (5.7) as follows:
yi|zij ,$i,ai,wi, ui, vij ∼ N (XiB +Zi$i + ϑ1vij , ϑ2σ2vij) ,
zij |ai,wi, ui ∼ Nni
(
z∗ij + δ[wi − J(ν)1ni ], u−1i σ21Ini
)
,
ai ∼ N3 (0,Σa) , $i ∼ N4 (0,Σ$) ,
wi|ui ∼ Nni(0, u−1i Ini)I(wi > 0),
ui|ν ∼ Γ(ν/2, ν/2), vij ∼ Exp(1/σ2),
Ti ∼ F (ti|di) =
∫
f(ρi|di),
(5.10)
where ϑ1 = (1− 2τ)/[τ(1− τ)] and ϑ2 = 2/[τ(1− τ)].
Under the Bayesian framework, after denoting θ = {α,B,γ, σ21, σ2,Σa,Σ$, δ, ν} as the
collection of unknown population parameters in the joint models (5.1), (5.6), and (5.7),
then we specify prior distributions for all of these unknown parameters as follows:
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α ∼ N3(α0,Ω1), B ∼ N4(β0,Ω2), γ ∼ N4(γ0,Ω3),
σ21 ∼ IG(ω1, ω2), σ2 ∼ IG(ω3, ω4),
Σa ∼ IW (Ω4, ω5), Σ$ ∼ IW (Ω5, ω6),
δ ∼ N(0, ω7), ν ∼ Exp(ν0)I(ν0 > 3)
(5.11)
where the mutually independent Normal (N), Inverse Gamma (IG), Inverse Wishart (IW )
and Exponential (Exp) prior distributions are chosen to facilitate computations. The super-
parameter matrices Ωk (k = 1, . . . , 5) can be assumed to be diagonal for convenient imple-
mentation. The exponential prior for ν is truncated to lie above 3 to make variance of ST
distribution well-defined.
Let f(·), f(·|·), F (·|·) and pi(·) denote a density function, a conditional density func-
tion, a cumulative density function (c.d.f) and a prior density function, respectively. Since
α,B,γ, σ21, σ2,Σa,Σ$, δ, and ν are assumed to be independent of each other, we have
pi(θ) = pi(α)pi(B)pi(γ)pi(σ21)pi(σ2)pi(Σa)pi(Σ$)pi(δ)pi(ν). Subsequently, after specifying the
joint models for the observed data and the prior distributions for the unknown parameters,
we can make Bayesian inference for the parameters based on their posterior distributions.
Thus, the joint posterior density of θ based on the observed dataD = {(qij , cij , zij , xi, ρij), i =
1, . . . , n; j = 1, . . . , ni} can be given by
f(θ|D) ∝ {
n∏
i=1
∫ ∫ ni∏
j=1
f(yij |zij ,$i,ai,wi, ui, vij)1−cijF (ζ|zij ,$i,ai,wi, ui, vij)cij
f(zij |ai,wi, ui)f(wi|ui,wi > 0)f(ui)f(ρi|di)f($i)f(ai)f(vij)d$idai}pi(θ).
(5.12)
Generally, the MCMC procedure is also used to sample population parameters θ, and
random-effects ai and $i (i = 1, . . . , n), from conditional posterior distributions based
on (5.12), by employing the Gibbs sampler along with the Metropolis-Hastings (M-H) al-
gorithm. This process is implemented using WinBUGS software [87] interacted with bugs
function in a package named R2WinBUGS of R.
61
5.4 Application to MACS data
5.4.1 Model implementation
As we discussed in Section 5.2, the proposed QR-based PLMJM specifies a quadratic poly-
nomial LME model (5.2) for CD4 process, a PLMM (5.6) for the longitudinal viral load
process, and a Cox proportional hazard model (5.9) for time-to-event process. Along with
the nature of the MACS data, the following three statistical models with specifying different
distributions based on the joint models, and one TS model are implemented to compare
their performance:
• Model ST: eij and ij follow ALD and ST distribution, respectively.
• Model SN: eij and ij follow ALD and SN distribution, respectively.
• Model N: eij and ij follow ALD and normal distribution, respectively.
• TS Model ST: eij and ij follow ALD and ST distribution, respectively.
Since a normal distribution is a special case of an SN distribution when skewness param-
eter is zero and is commonly used in other studies, we investigate how the covariate model
(5.1) using an asymmetric (SN or ST) distribution contributes to modeling results and
parameter estimation, in comparison with that using a symmetric (normal) distribution.
To perform the Bayesian inference process, we have to specify the values for the hyper-
parameters in the prior distributions (5.11). Weakly informative prior distributions for the
parameters are taken in joint models. Particularly, (i) fixed-effects are taken to be indepen-
dent normal distribution N(0, 100) for each element of the population parameter vectors α,
β, and γ; (ii) we assume a noninformative inverse Gamma prior distribution IG(0.01, 0.01),
which has mean 1 and variance 100, for scale parameter σ21 and σ2 ; (iii) the priors for the
variance-covariance matrices of the random-effects Σa and Σ$ are taken to be inverse
Wishart distributions IW (diag(0.01, 0.01, 0.01), 3) and IW (diag(0.01, 0.01, 0.01, 0.01), 4);
(iv) for the skewness parameter δ, a normal distributions N(0, 100) is chosen; (v) the degree
of freedom parameter ν follows truncated exponential distribution with ν0 = 0.5.
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The MCMC sampler was implemented using WinBUGS software interacted with R2WinBUGS
of R software. The WinBUGS code is attached in Appendix C. Convergence of the gener-
ated samples was assessed using standard tools within WinBUGS software such as trace
plots and Gelman-Rubin (GR) diagnostics [88]. Figure 8 shows the trace plots, autocorre-
lation and dynamic version of GR diagnostic plots based on Model ST for the representative
parameters β, α1, γ1, and δ. All of these plots implies that convergence is reached.
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Figure 8: Convergence diagnostics for representative parameters based on QR-based par-
tially linear mixed-effects joint models (Model ST) with τ = 0.5: trace plots (left panel);
Autocorrelation plots (middle panel); Gelman-Rubin (GR) diagnostic plots (right panel)
When convergence achieved, we proposed that, after an initial number of 50,000 burn-in
iterations of three chains of length 100,000, every 50th MCMC sample was retained from
the next 50,000 for each chain. Thus, we obtained a total of 3,000 samples of targeted
posterior distributions of the unknown parameters for statistical inference.
63
5.4.2 MACS Data analysis results
Bayesian joint modeling approach at the five quantiles of τ = 0.05, 0.25, 0.50, 0.75 and 0.95
was used to fit the viral load, CD4, and time-to-event data jointly. Table 6 presents the
population posterior mean, the corresponding 95% CI for fixed-effects parameters based on
the three proposed joint models (N, SN and ST). The following findings are obtained for
the results of estimated parameters.
We firstly check the fixed-effects parameters from QR-based PLMM (5.6) for the lon-
gitudinal viral load process. Interestingly, for the key parameter β quantifying the effect
of CD4 cell counts on viral load, its estimates are all significant but with varying negative
values at five different quantiles in all three models. In details, under the same models,
the largest estimated value of β appears at median (τ = 0.50), and the smallest value is
found at τ = 0.95. The estimated values of β reveal a “flat arch” shape at different quan-
tiles (Figure 9(a)), which suggests a distinct strength of the negative relationship between
viral load and CD4 counts in the population level at different quantiles. Furthermore, in
comparison of Models ST, SN and N, the values of estimated β at the same quantile are
smaller in Models ST and SN than their counterparts in Model N, whereas those in Models
ST and SN are comparable. This finding may indicate an underestimated negative CD4
effect by employing a joint models with covariate model errors following normal distribu-
tion. In addition to the parametric part, differences of the parameters estimates in the
nonparametric part at different quantiles are also detected. As τ increases, the estimates
of ξ1 increase; from lower quantiles to the median, the estimates of ξ2 increase, while those
of ξ3 decrease; reversely, from the median to higher quantiles, the estimates of ξ2 decrease
and those of ξ3 increase. Figure 9(d)-(h) clearly present the different patterns of the esti-
mated nonparametric function g(t) at five different quantiles in three models. In general,
g(t) decreases initially and then rebounds, but the decrease and rebound rates are smaller
when τ = 0.05 and 0.95, compared to those at other quantiles. Though there are slight
deviations among the estimated g(t) curves in different models, the estimates of parameters
in the nonparametric part are comparable, except those at τ = 0.50.
For parameters of CD4 covariate model (5.2), the estimated results at the five quan-
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Figure 9: The population-level estimated result: (a) Strength of the correlation between
viral load and CD4 counts under different scenarios; (b) Strength of the association be-
tween CD4 effect and death risk under different scenarios; (c) Strength of the association
between seroconversion age and death risk under different scenarios; (d)-(h) The population
estimating curves of g(t) based on the three models at five different quantiles, respectively.
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Table 6: Summary of estimated posterior mean (PM) of population (fixed-effects) parame-
ters, the corresponding lower limit (LCI) and upper limit (UCI) of 95% equal-tail credible
interval (CI) as well as DIC values for QR-based PLMJM
Method Model β ξ1 ξ2 ξ3 α1 α2 α3 γ1 γ2 γ3 γ4 δ ν DIC
τ = 0.05
JM ST PM -0.59 -25.20 4.15 -9.11 0.58 -6.20 7.90 -0.42 -0.17 0.16 0.25 0.53 3.75 71205.4
LCI -0.89 -25.54 -14.95 -28.63 0.50 -7.07 6.25 -1.50 -0.21 -0.01 -0.21 0.49 3.19
UCI -0.26 -24.85 23.77 10.38 0.67 -5.31 9.50 0.81 -0.13 0.33 0.75 0.56 4.41
JM SN PM -0.58 -25.19 4.51 -8.93 0.60 -6.27 7.84 -0.54 -0.15 0.18 0.24 0.73 – 75318.0
LCI -0.91 -25.52 -14.64 -27.37 0.51 -6.88 6.72 -1.62 -0.19 0.01 -0.22 0.70 –
UCI -0.27 -24.86 22.58 11.13 0.68 -5.66 8.93 0.68 -0.12 0.34 0.72 0.76 –
JM N PM -0.51 -25.19 4.52 -8.88 0.70 -7.56 9.94 -0.56 -0.13 0.19 0.26 – – 75526.8
LCI -0.87 -25.54 -15.08 -27.17 0.61 -8.32 8.35 -1.56 -0.16 0.02 -0.22 – –
UCI -0.18 -24.88 23.75 10.08 0.79 -6.73 11.36 0.48 -0.11 0.35 0.79 – –
τ = 0.25
JM ST PM -0.55 -2.01 14.93 -26.42 0.60 -6.41 8.20 -2.28 -0.17 0.22 0.34 0.53 3.75 58564.1
LCI -0.72 -2.20 -4.92 -44.99 0.52 -7.12 7.00 -3.56 -0.21 0.04 -0.23 0.49 3.16
UCI -0.38 -1.82 34.48 -8.18 0.69 -5.69 9.48 -1.31 -0.13 0.43 0.97 0.56 4.45
JM SN PM -0.56 -2.02 14.70 -26.47 0.61 -6.74 8.74 -2.26 -0.16 0.24 0.32 0.72 – 62665.3
LCI -0.71 -2.20 -4.51 -45.28 0.53 -7.49 7.68 -3.47 -0.20 0.05 -0.24 0.69 –
UCI -0.40 -1.81 34.15 -7.60 0.70 -6.05 9.98 -1.33 -0.12 0.45 0.90 0.76 –
JM N PM -0.52 -2.03 14.22 -25.91 0.70 -7.63 10.08 -1.86 -0.14 0.27 0.32 – – 62849.1
LCI -0.71 -2.20 -5.98 -45.59 0.60 -8.53 7.98 -2.98 -0.18 0.06 -0.23 – –
UCI -0.32 -1.83 34.58 -6.95 0.81 -6.36 11.83 -1.06 -0.11 0.48 0.89 – –
τ = 0.50
JM ST PM -0.54 2.76 18.80 -28.75 0.58 -6.12 7.74 -2.78 -0.16 0.23 0.34 0.53 3.75 54939.5
LCI -0.69 2.54 -0.30 -49.69 0.50 -7.07 6.26 -4.30 -0.21 0.03 -0.23 0.49 3.15
UCI -0.39 3.07 39.39 -5.95 0.67 -5.24 9.49 -1.56 -0.12 0.43 0.96 0.57 4.46
JM SN PM -0.55 2.70 18.75 -32.50 0.61 -6.59 8.39 -2.74 -0.16 0.25 0.30 0.73 – 59112.2
LCI -0.68 2.53 -1.87 -51.57 0.53 -7.20 7.40 -4.12 -0.20 0.05 -0.22 0.70 –
UCI -0.41 2.89 37.04 -14.61 0.70 -5.98 9.38 -1.61 -0.12 0.47 0.87 0.76 –
JM N PM -0.48 2.70 18.96 -30.40 0.69 -7.46 9.82 -1.34 -0.13 0.26 0.34 – – 59301.8
LCI -0.68 2.54 -0.16 -48.25 0.60 -8.45 8.49 -3.30 -0.17 0.05 -0.20 – –
UCI -0.25 2.89 37.45 -12.17 0.79 -6.68 11.79 3.30 -0.10 0.47 0.90 – –
τ = 0.75
JM ST PM -0.58 7.26 15.13 -28.21 0.59 -6.35 8.07 -2.23 -0.17 0.21 0.33 0.53 3.77 58153.8
LCI -0.74 7.08 -3.97 -46.63 0.50 -7.09 6.38 -3.61 -0.22 0.02 -0.16 0.49 3.19
UCI -0.42 7.44 36.26 -8.44 0.69 -5.27 9.39 -1.14 -0.13 0.40 0.85 0.56 4.48
JM SN PM -0.58 7.25 14.96 -27.74 0.62 -6.78 8.74 -2.33 -0.16 0.24 0.33 0.73 – 62265.7
LCI -0.73 7.08 -6.51 -45.40 0.54 -7.65 7.25 -3.75 -0.21 0.04 -0.21 0.69 –
UCI -0.42 7.45 34.29 -9.96 0.71 -5.96 10.53 -1.26 -0.12 0.44 0.92 0.76 –
JM N PM -0.55 7.26 14.77 -27.24 0.71 -7.76 10.31 -1.80 -0.14 0.26 0.34 – – 62434.9
LCI -0.76 7.08 -4.13 -46.82 0.61 -8.54 8.61 -2.82 -0.18 0.06 -0.22 – –
UCI -0.37 7.43 32.76 -8.77 0.80 -6.75 11.69 -1.02 -0.11 0.46 0.90 – –
τ = 0.95
JM ST PM -0.65 29.44 4.49 -9.72 0.57 -6.04 7.59 -0.38 -0.17 0.16 0.25 0.53 3.73 70997.3
LCI -0.96 29.12 -14.79 -27.76 0.48 -7.19 6.69 -1.54 -0.21 -0.02 -0.23 0.49 3.16
UCI -0.33 29.77 24.09 9.66 0.66 -5.50 9.52 -0.80 -0.13 0.32 0.69 0.56 4.43
JM SN PM -0.64 29.42 4.78 -9.66 0.62 -6.80 8.81 -0.46 -0.16 0.18 0.24 0.72 – 75119.1
LCI -0.95 29.11 -14.94 -29.75 0.53 -7.45 6.77 -1.58 -0.19 0.02 -0.20 0.69 –
UCI -0.35 29.75 23.58 10.13 0.70 -5.70 10.03 0.71 -0.12 0.34 0.70 0.75 –
JM N PM -0.62 29.43 4.78 -9.03 0.71 -7.71 10.23 -0.53 -0.13 0.18 0.25 – – 75365.4
LCI -0.95 29.13 -14.08 -28.69 0.62 -8.56 8.61 -1.69 -0.17 0.02 -0.19 – –
UCI -0.29 29.79 24.57 11.03 0.80 -6.86 11.72 0.57 -0.10 0.35 0.72 – –
tiles within single model are comparable. For example, in Model ST, the esitmates of the
intercept α1 ranges from 0.57 to 0.60, and estimates of α2 and α3 also vary slightly across
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five quantiles. The estimates of the linear coefficient α2 are significantly negative, which
suggests a negative linear relationship between CD4 cell counts and measurement time,
whereas the estimates of α1 and α3 are significantly positive. One of the objectives of this
study is to compare Models ST, SN and N. It is noted that the smallest estimated value of
α1 and α3 is found in Model ST, and the largest is found in Model N, while the estimated
α2 is exactly the opposite. Additionally, the estimated skewness parameter δ has a signifi-
cantly positive value in Models SN and ST. It confirms that a significantly positive (right)
skewness exists in the CD4 data. Interestingly, the estimated δ in Model ST is smaller than
that in Model SN. It could be explained by the additional parameter, degrees of freedom ν,
in Model ST, which is also significantly positive.
Furthermore, some interesting findings are found in Cox proportional hazard model
(5.9) for time-to-event process. From lower quantiles to the median, the estimates of γ3
(Figure 9(b)) and γ4 increase, while that of γ1 decreases (Figure 9(c)); reversely, from the
median to higher quantiles, the estimates of γ3 and γ4 decline, while that of γ1 goes up.
However, no such trend is detected on γ2, which is changeless at different quantiles. Take
γ3 as a case here, its estimates are significant at quantiles of τ = 0.25, 0.50 and 0.75, and
higher than those at quantiles of τ = 0.05 and 0.95. It indicates that age at seroconversion
is a risk factor of death for most of the HIV patients, but not for subjects with extremely
low or high viral load. Comparing Models ST, SN and N, no obvious difference is discovered
for parameter estimates in Cox proportional hazard model, except γ1.
We further compute the DIC (Table 6) to select the best model that fits the data
adequately. The DIC values in Model ST are smaller than their counterparts in Models SN
and N at the same quantile of τ . Within any one of these three models, the DIC value is
the smallest at the quantile of τ = 0.50, whereas it is the largest at the quantile of τ = 0.05.
It suggests that the smaller amount of information is available at more extreme quantiles
(e.g. τ = 0.05 or τ = 0.95). Therefore, according to the DIC, the ST model-based median
regression (τ = 0.50) is the best fitting model, because of the smallest DIC (54939.5).
Thus, our results suggest that it is highly recommended to assume an ST distribution for
the covariate model in order to achieve more reliable results, particularly when the CD4
data exhibits non-normality.
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We also compared the results of joint model ST and two-stage ST model. The estimates
of parameters on longitudinal and covariate processes are comparable, but big estimated
differences are found on some parameters of Cox regression model. Table 7 shows the hazard
ratios (HR) and corresponding 95%CI from the joint and two-stage ST models. The HR1
is underestimated in the TS model at different quantiles, except τ = 0.50, compared to the
joint model. No obvious difference was found for HR2, HR3 and HR4 between the joint
model and TS model. Due to the biased estimates of the TS model, the results of the joint
models are preferred.
Table 7: Summary of estimated posterior mean (PM) of Hazard ratios, the corresponding
lower limit (LCI) and upper limit (UCI) of 95% equal-tail credible interval (CI) for joint
and two-stage ST models
Method Model HR1 HR2 HR3 HR4
τ = 0.05
JM ST PM 0.66 0.84 1.17 1.28
LCI 0.22 0.81 0.99 0.81
UCI 2.25 0.88 1.39 2.12
TS ST PM 0.00 0.86 1.14 1.32
LCI 0.00 0.84 0.97 0.89
UCI 0.01 0.88 1.32 2.03
τ = 0.25
JM ST PM 0.10 0.84 1.25 1.40
LCI 0.03 0.81 1.04 0.79
UCI 0.27 0.88 1.54 2.64
TS ST PM 0.00 0.87 1.18 1.35
LCI 0.00 0.84 1.02 0.92
UCI 0.01 0.89 1.37 2.10
τ = 0.50
JM ST PM 0.06 0.85 1.26 1.40
LCI 0.01 0.81 1.03 0.79
UCI 0.21 0.89 1.54 2.61
TS ST PM 0.12 0.88 1.13 1.23
LCI 0.02 0.85 0.98 0.82
UCI 0.71 0.90 1.31 1.89
τ = 0.75
JM ST PM 0.11 0.84 1.23 1.39
LCI 0.03 0.80 1.02 0.85
UCI 0.32 0.88 1.49 2.34
TS ST PM 0.03 0.86 1.14 1.33
LCI 0.00 0.84 0.99 0.90
UCI 0.25 0.88 1.32 2.02
τ = 0.95
JM ST PM 0.68 0.84 1.17 1.28
LCI 0.21 0.81 0.98 0.79
UCI 0.45 0.88 1.38 1.99
TS ST PM 0.00 0.86 1.15 1.33
LCI 0.00 0.84 0.99 0.90
UCI 0.16 0.88 1.33 2.00
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Thus, we report findings based on Model ST to further understand the joint mod-
els in detail. First, the parameter estimate of β, which quantifies the association be-
tween viral load and CD4 cell counts, varies from -0.54 with 95%CI: (-0.69, -0.39) at
τ = 0.50 to -0.65 with 95%CI: (-0.96, -0.33) at τ = 0.95. From the pathogenesis point
of view, since the CD4 cells fight HIV infection, the negative association between these two
biomarkers is well known, but more interestingly, the association is heterogeneous. The
stronger association at the 95th quantile implies a better HIV treatment ART effect for
the AIDS patients with high-level viral load or severe AIDS patients. Besides, the as-
sociation at τ = 0.05 is relatively stronger (β = −0.59, 95%CI : [−0.89,−0.26]), which
could be partially explained by the fact that in the early stage of disease, patients may
be more sensitive to the treatment. The above findings may not be revealed from tradi-
tional mean regression models. Second, the estimates of parameters in covariate model
vary little at different quantiles. When τ = 0.50, the estimated results indicate that the
population CD4 trajectory may be approximated by the quadratic polynomial LME model:
zˆ∗(t) = 325.01(0.58 − 6.12t + 7.74t2) + 556.25, where zˆ∗(t) is in the original CD4 scale.
Correspondingly, the population viral load process may be approximated by the PLMM:
Vˆ (t) = −0.54zˆ∗(t) + 2.76ψ0(t) + 18.80ψ1(t) − 28.75ψ2(t). Third, based on the Cox pro-
portional model, we find that lower CD4 effect (HR1 = 0.06, 95%CI : [0.01, 0.21]), faster
CD4 decline rate (HR2 = 0.85, 95%CI : [0.81, 0.89]), and higher age at seroconversion
(HR3 = 1.26, 95%CI : [1.03, 1.54]) are significantly associated with higher risk of death
when τ = 0.50. And the strength of the association becomes weaker among patients with
extreme low or high viral load. However, the race were not found to be significantly as-
sociated with the risk of death. Remind that this simple approximation considered here
only provides a rough guidance and point to further research because the true association
described above may be complicated.
5.5 Simulation studies
To assess performance of the proposed QR-based PLMJM and method, we conducted the
following simulation studies. The design of the simulated data is similar to the MACS data
we used. Specifically, we generated the sample size n =300, and assumed that each subject
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had 23 scheduled longitudinal measurements. The measurement time points generated in
the simulation are mimicked those in the real data analysis, and the true parameter values
are selected as follows: β = −5, ξ3 = (ξ1, ξ2, ξ3)T = (10, 10, 10)T , α = (α1, α2, α3)T =
(−5,−6,−10)T , γ = (γ1, . . . , γ4)T = (2, 2, 2, 2)T , $i ∼ N(0,diag(1, 1, 1, 1)). The time-
varying CD4 covariate zij is generated based on equation (5.2) with (ai1, ai2, ai3)
T ∼
N(0,diag(1, 1, 1)); we simulated the model errors eij and ij from a Γ(2, 1) distribution,
then subtracted by 2, which yields a skewed distribution with the mean 0 and variance 2.
To mimic the LOD, we selected the 15th quantile of the longitudinal response as a cut-of
threshold so that 15% of the outcome is below LOD. To generate the time-to-event data, we
set constant baseline hazard of 0.1, and used an exponential distribution with mean equal
to 0.1 to generate censoring time. Covariates in Cox proportional regression model were
simulated depending on variable types. For example, race and age, were simulated from a
Bernoulli distribution with p = 0.8, and a normal distribution with mean 35 and standard
deviation 8, respectively. Due to the intensive computational load, we generated 50 data
sets, which were fitted by Models N, SN and ST at three different quantiles of τ = 0.25, 0.50
and 0.75. Note that the prior distributions considered are all close to non-informative as
similarly treated in real data analysis. Thus, we expect the results to be somewhat robust
with respect to prior distributions.
Table 8 summarizes the simulation results which include the true parameter (TP)
values, percent bias (defined by 100 × biasl/|TPl|) and percent MSE (defined by 100 ×
√
MSEl/|TPl|) of fixed-effects β, ξ3, α, and γ. First, it is of interest to see that the esti-
mated β vary at different τ under any scenario. It confirms that the proposed QR-based
PLMJM can be applied to detect the heterogeneous effects of covariate at different quantiles
of the outcome. Second, in comparison of Models ST, SN and N at the same quantiles, we
found that Model ST outperforms Models SN and N in terms of smaller bias and MSE,
excluding ξ1 at τ = 0.25 and 0.75, and ξ2 at τ = 0.25 (in these scenarios, Model SN per-
forms the best). We noted that the big bias of the intercept parameter ξ1 at τ = 0.25 and
0.75 is reasonable under QR-based models, which is in consistent to the results of real data
analysis. Third, for parameters in covariate model, it is obvious that Model ST (bias ranges
from −7.83% to 16.74%) beats the competitors Models SN (bias ranges from −11.14% to
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21.81%) and N (bias ranges from −10.43% to 24.07%). Fourth, according to the estimates
of parameters in Cox proportional hazard models, Models ST and SN are comparable, and
both of them performs better than Model N. Therefore, the simulation results confirm the
importance of accounting for skewness in the data.
Table 8: Summary of true parameter (TP) values, estimated parameters, Bias and MSE for
Models N, SN and ST based on 50 simulated data sets.
TP Model N Model SN Model ST
τ = 0.25 τ = 0.50 τ = 0.75 τ = 0.25 τ = 0.50 τ = 0.75 τ = 0.25 τ = 0.50 τ = 0.75
β = −5 EST -5.10 -5.08 -3.45 -5.10 -5.09 -3.46 -5.08 -5.07 -3.48
Bias -2.03 -1.62 30.92 -2.00 -1.80 30.70 -1.70 -1.37 30.42
MSE 2.20 1.91 31.00 2.22 1.97 30.75 2.08 1.63 30.47
ξ1 = 10 EST 3.79 11.00 42.04 3.96 11.14 41.78 3.88 10.89 41.91
Bias -62.05 9.96 320.36 -60.44 11.44 317.77 -61.14 8.90 319.14
MSE 62.09 10.32 320.68 60.48 11.82 317.96 61.16 9.40 319.30
ξ2 = 10 EST 10.08 10.07 9.72 10.01 10.06 9.69 10.02 10.07 9.74
Bias 0.80 0.66 -2.78 0.09 0.57 -3.14 0.18 0.69 -2.62
MSE 1.07 0.90 2.82 0.54 0.88 3.21 0.70 0.87 2.73
ξ3 = 10 EST 9.91 9.86 9.43 9.91 9.86 9.45 9.93 9.87 9.46
Bias -0.89 -1.37 -5.65 -0.88 -1.37 -5.55 -0.71 -1.31 -5.42
MSE 1.10 1.49 5.68 1.04 1.42 5.59 1.00 1.38 5.45
α1 = −5 EST -4.54 -5.13 -5.45 -4.56 -4.61 -5.24 -4.72 -4.90 -5.23
Bias 9.17 -2.51 -8.98 8.75 7.77 -4.83 5.51 1.96 -4.64
MSE 9.29 2.87 9.68 8.85 8.08 5.02 5.58 2.91 5.16
α2 = −6 EST -4.89 -4.73 -4.56 -4.94 -4.80 -4.69 -5.43 -5.27 -5.00
Bias 18.46 21.11 24.07 17.65 19.93 21.81 9.48 12.12 16.74
MSE 18.51 21.15 24.12 17.69 19.96 21.86 10.14 12.17 16.81
α3 = −10 EST -11.04 -10.86 -10.64 -11.11 -10.87 -10.62 -10.78 -10.57 -10.40
Bias -10.43 -8.63 -6.41 -11.14 -8.73 -6.18 -7.83 -5.74 -4.00
MSE 10.51 8.65 6.46 11.17 8.75 6.23 7.87 5.77 4.10
γ1 = 2 EST 2.43 2.08 2.62 2.24 2.19 2.30 2.18 2.07 2.35
Bias 21.74 3.91 31.17 11.96 9.64 14.95 9.00 3.64 17.59
MSE 27.48 7.51 39.93 15.48 17.57 20.20 14.73 13.36 24.36
γ2 = 2 EST 2.14 1.88 2.06 2.06 1.98 2.18 2.08 1.94 2.02
Bias 6.81 -5.80 3.06 2.95 -0.83 9.16 3.95 -3.15 0.87
MSE 14.28 9.40 8.60 8.63 7.47 20.89 10.42 8.90 10.29
γ3 = 2 EST 2.19 1.88 2.17 2.04 1.89 2.28 2.05 1.86 2.01
Bias 9.63 -5.78 8.56 1.77 -5.71 13.78 2.68 -7.16 0.49
MSE 15.84 13.08 19.69 9.05 11.34 18.08 8.44 10.02 5.83
γ4 = 2 EST 2.08 1.91 2.15 2.01 2.03 2.04 2.09 1.91 2.05
Bias 3.94 -4.61 7.31 0.29 1.50 1.78 4.77 -4.51 2.73
MSE 14.94 17.49 19.36 5.38 7.23 9.02 11.53 11.73 9.31
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5.6 Concluding discussion
In this chapter, we proposed a QR-based PLMJM with response, covariate, and time-
to-event processes under the Bayesian framework. The corresponding QR-based PLMM,
quadratic polynomial LME model, and Cox proportional hazard model are linked through
the random-effects that characterize the underlying individual-specific longitudinal process.
We also considered some common but important data features which may affect the discov-
ery of the true disease progression, including CD4 covariate measurement errors, skewness,
and viral load below LOD. To the best of our knowledge, it is the first time of jointly mod-
elling QR-based PLMM, covariate measurement error model with SN/ST distributions, and
Cox proportional hazard model, accounting for multiple data features simultaneously.
The proposed QR-based joint models have many advantages compared to traditional
mean-regression models. First, the QR-based PLMJM fully scanned the association between
viral load and CD4 cell counts, and discovered the heterogeneous CD4 effect at different
quantiles. Specifically, the strongest negative effect was found at quantile τ = 0.95, and
the second strongest was detected at quantile τ = 0.05. These interesting findings have
important clinical meaning. In one hand, it suggests that ART is more effective for those
patients with higher viral load at higher risk. In the other hand, the patients may be also
more sensitive to the treatment in early stages of HIV infection. Thus, once the disease is
discovered when the viral load is still low, the infected patients should take the treatment as
soon as possible. These findings make sense under the biological mechanism. Second, from
the Cox proportion hazard models, we found that lower CD4 effect, faster CD4 decline rate
and higher age at seroconversion are associated with the higher risk of death. As we known,
CD 4 cell is one of the most important sources to clear out HIV virus, and as the patients
grow older, their immune system become weaker and slower to respond. Interestingly, the
strength of the association is also varying at different quantiles. For patients with extremely
low or high viral load, the strength of the association is smaller, and the association is even
not significant.
Since it is of importance to measure CD4 cell counts appropriately when it exhibits
skewness and heavy tails, this study considered three models (Models N, SN and ST)
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with different scenarios. We found that Model ST is favorable to other two models, and
performs the best. In model ST, the estimates of skewness parameter δ and the degrees of
freedom ν are around 0.53 and 3.75 at the 50th quantile, respectively, indicating that the
positive skewness with heavy tail exist in the CD4 cell counts. Compared to Model SN,
the magnitude of estimated δ is smaller in Model ST. This could be explained by the fact
that the additional parameter ν for heaviness in the tails of ST distribution reduces the
effect of skewness. The simulation studies also confirmed the results. Therefore, the ST/SN
distribution provide more efficiency and accuracy in parameter estimation, and serve as a
better alternative to normal (symmetric) distribution, which is widely assumed in statistical
models.
In summary, this chapter proposed a novel flexible joint models to comprehensively
quantify complicated HIV disease mechanism in both longitudinal and time-to-event pro-
cesses. Although the proposed joint models are complicated with heavy computational load,
the idea and methodology introduced here is applicable to a broader field in practice.
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Chapter 6 Conclusion and future research
In this dissertation, we proposed three QR-based joint models under the Bayesian frame-
work, including QR-based nonlinear mixed-effects joint models for longitudinal-survival
data, QR-based PLMM for longitudinal data, and QR-based PLMJM for longitudinal-
survival data. Three important data features, LOD, measurement error and skewness of
covairate, are also considered simultaneously. Although this study is motivated by the
MACS data, these novel models and method have broader applications, and flexibility for
practitioners to analyze complex longitudinal and survival data under relevant specifica-
tions.
These novel QR-based joint models we developed have many advantages. First of all,
compared to traditional mean-regression based joint models, our QR-based joint models
can capture the full nature of the distinct relationships between outcome and covariates,
and heterogeneous longitudinal dynamics. For example, the results from the MACS data
suggest that ART is more effective for HIV patients with higher viral load, and patients at
early stage. Second, our QR-based joint models are more robust, when the outcome has
outliers/extreme values. Third, with the application of skew distributions, including SN
and/or ST distributions, our joint models considered CD4 cell counts measurement error
appropriately when it exhibits skewness and heavy tails. Simulation studies also confirmed
and proved our findings that skew distributions could provide more accurate estimation.
Finally, we extended the LME joint models to nonlinear mixed-effects joint models, and
partially linear mixed-effects models with more flexibility. Thus, according to the claim
of “evidence-based medicine” and “precision medicine”, our QR-based joint models have
the capability to provide more accurate information/evidence to physicians, benefiting their
clinical decision making and treatment evaluation.
A full Bayesian inference approach, which is powerful when the dimension of parameters
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in the complicated joint models is high, was adopted to get the point estimates and 95%CI
for parameters of interest. For inference of QR-based joint models, parameter and/or model
identifiability is an important but difficult issue when a large number of parameters must be
estimated simultaneously. So we prefer parsimonious models containing fewer parameters,
especially for models of secondary interest such as the covariate model whose parameters
could be treated as nuisance parameters. Fortunately, for these nonlinear and partially
linear joint models considered in this research, parameter identifiability is often less of a
concern than linear models [95]. In practice, if the models are not identifiable, the MCMC
algorithm would diverge quickly. In the application considered in this study, the MCMC
algorithm converged without problems and we did not observe potential identifiability issues.
The joint models considered in this article can be easily fitted using MCMC procedure
via the WinBUGS package interacted with R software that are available publicly. This makes
our approach quite powerful and accessible to practical statisticians in the fields. However,
due to the intensive computational time for such a complicated modelling approach, we did
only relatively small number of replications for each joint models with different scenarios in
the simulation studies, which may have a chance to increase the bias. However, the variation
of each parameter of interest was small, indicating that the results of our simulation studies
were reliable. This relatively long computing time could likely be lessened by using parallel
computing in the future.
This dissertation research combined new technologies in mathematical modeling and
statistical inference with advances in HIV/AIDS dynamics to quantify complex HIV disease
mechanism. The complicated nature of HIV/AIDS will naturally pose some challenges such
as missing values, and multiple failure types. We may further extend our joint models to
more complicated cases. For example, (i) consider the missing covariates by introducing
simple non-ignorable model for missing mechanism; (ii) jointly model the longitudinal and
competing risk processes. These complicated problems are beyond the focus of this article,
but a further study may be warranted. We are actively investigating these interesting issues
and hope that we could report these related results in the near future.
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Appendix A: R and WinBUGS program codes for Model SN
in Chapter 3
## R program code
library(arm)
library(R2WinBUGS)
data<-list(......)
inits<-list() # Run three chains
inits[[1]]<-list(......)
inits[[2]]<-list(......)
inits[[3]]<-list(......)
parameters<-c(......)
RNAdynamic.QR<-bugs(data, inits, parameters, "Chapter3-SN.txt",n.chains=3,
n.thin=50, n.iter=150000,n.burnin=100000,bugs.seed=654321,
bugs.directory="C:\\Users\\WinBUGS14",DIC=TRUE,debug=TRUE)
## WinBUGS program code named Chapter3-SN.txt
model
{
for (i in 1:n) #total number of subjects
{
# Latent random variables generated by SN dist.
u.e[i] ~ dgamma(d1,d1)
# Random effects of response model
b0[i,1]<-0
b0[i,2]<-0
b0[i,3]<-0
b0[i,4]<-0
b[i,1:4]~dmnorm(b0[i,1:4], Omega[,])
# Random effects of covariate model
a3[i,1]<-0
a3[i,2]<-0
a3[i,3]<-0
a[i,1:3]~dmnorm(a3[i,1:3], Omega3[,]) }
for (i in 1:n) #Cox regression model
{for(j in 1:Tnum) {
risk[i,j] <- step(obs.t[i] - t[j] + eps)
dN[i,j] <- risk[i, j] * step(t[j + 1] - obs.t[i] - eps) * fail[i] }}
for(j in 1:Tnum)
{for(i in 1:n) {
dN[i, j] ~ dpois(Idt[i, j])
Idt[i, j] <- risk[i, j]*exp(gamma[1]*b[i,2]+gamma[2]*b[i,4]
+gamma[3]*age[i]+gamma[4]*race[i])*dL0[j] }
dL0[j] ~ dgamma(mucox[j], c)
mucox[j] <- dL0.star[j]*c
}
c <- 0.001
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r <- 0.1
for (j in 1 : Tnum)
{ dL0.star[j] <- r * (t[j + 1] - t[j]) }
for (j in 1:N) #total number of measurements
{ #Measurement error model with SN distribution
z.star[j]<-(alpha[1]+a[y[j,1],1])+(alpha[2]+a[y[j,1],2])*Z[j,3]
+(alpha[3]+a[y[j,1],3])*Z[j,4]
w[j] ~ dnorm(0,1)I(0,)
z.mu[j]<-z.star[j]+delta*(w[j]-0.798)
y[j,6] ~ dnorm(z.mu[j], Isigma2)
# y[j,1]=patid, y[,3]=time, y[j,6]=standardized cd4
# Response models with ALD dist. (tau=0.50)
p1[j] <-beta[1] +b[y[j,1],1]
lambda1[j] <-beta[2]+beta[3]*base[y[j,1],3] +b[y[j,1],2]
p2[j] <-beta[4] +b[y[j,1],3]
lambda2[j] <-beta[5]+beta[6]*z.star[j] +b[y[j,1],4]
dm1[j]<-p1[j]-step(lambda1[j]-lambda2[j])*lambda1[j]*y[j,3]
dm2[j]<-p2[j]-step(lambda1[j]-lambda2[j])*lambda2[j]*y[j,3]
dm3[j]<-exp(dm1[j])
dm4[j]<-exp(dm2[j])
dm[j]<- dm3[j]+dm4[j]
v.ald[j] ~ dexp(Isigma)I(1,)
mu[j]<-log(dm[j])/log(10)+(1-2*tau)/(tau*(1-tau))*v.ald[j]
aau[j]<-(tau*(1-tau))/(2*sigma*v.ald[j])
# LOD
upper.limit[j] <-Below.detection*y[j,13]+upper.bound*(1-y[j,13])
y[j,12] ~dnorm(mu[j], aau[j])I(,upper.limit[j])
# y[j,13]=censoring indicator, y[,12]=log(viral load)
}
# Prior distributions of the hyperparameters
#(1) Coefficients
for(k in 1:6){beta[k]~dnorm(0,0.01)}
for(k in 1:4){gamma[k]~dnorm(0,0.01)}
for(k in 1:3){alpha[k]~dnorm(0,0.01)}
#(2) Skewness parameters
delta ~ dnorm(0, 0.01)
#(3) Precision parameters
Isigma~dgamma(0.01,0.01)
sigma<-1/Isigma
Isigma2~dgamma(0.01,0.01)
sigma2<-1/Isigma2
#(4) Variance-covariance matrix
Omega[1:4,1:4] ~ dwish(R[,],4)
V1[1:4,1:4]<-inverse(Omega[,])
Omega3[1:3,1:3] ~ dwish(R3[,],3)
V3[1:3,1:3]<-inverse(Omega3[,])
}
##End of model
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Appendix B: WinBUGS program code for Model ST in
Chapter 4
## WinBUGS program code named Chapter4-ST.txt
model
{
for (i in 1:n) #total number of subjects
{
# Latent random variables generated by ST dist.
u.e[i] ~ dgamma(d1,d1)
# Random effects of response model
b0[i,1]<-0
b0[i,2]<-0
b0[i,3]<-0
b0[i,4]<-0
b[i,1:4]~dmnorm(b0[i,1:4], Omega[,])
# Random effects of covariate model
a3[i,1]<-0
a3[i,2]<-0
a3[i,3]<-0
a[i,1:3]~dmnorm(a3[i,1:3], Omega3[,])
}
for (j in 1:N) #total number of measurements
{ #Measurement error model with ST distribution
w2[j] ~ dnorm(0, u.e[y[j,1]])I(0,)
aau2[j]<-u.e[y[j,1]]*Isigma2
z.star[j]<-(alpha[1]+a[y[j,1],1])+(alpha[2]+a[y[j,1],2])*y[j,3]
+(alpha[3]+a[y[j,1],3])*y[j,3]*y[j,3]
z.mean[j]<- z.star[j]+delta*(w2[j]-mue2)
y[j,6] ~ dnorm(z.mean[j], aau2[j])
# y[j,1]=patid, y[,3]=time, y[j,6]=standardized cd4
# Response models with ALD dist. (tau=0.50)
para[j] <- z.mean[j]*(beta[1]+b[y[j,1],1])
npara[j] <-(beta[2]+ b[y[j,1],2])+(beta[3]+ b[y[j,1],3])*spline[j,3]
+(beta[4]+ b[y[j,1],4])*spline[j,4]
dm[j] <- para[j] + npara[j]
v.ald[j] ~ dexp(Isigma)I(1,)
mu[j]<-dm[j]+(1-2*tau)/(tau*(1-tau))*v.ald[j]
aau[j]<-(tau*(1-tau))/(2*sigma*v.ald[j])
# LOD
upper.limit[j] <-Below.detection*y[j,13]+upper.bound*(1-y[j,13])
y[j,12] ~dnorm(mu[j], aau[j])I(,upper.limit[j])
# y[j,13]=censoring indicator, y[,12]=log(viral load)
}
# Prior distributions of the hyperparameters
#(1) Degree of freedom
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nu ~ dexp(0.1) I(3,)
mue2 <- exp(loggam(0.5*(nu-1.))-loggam(0.5*nu))*sqrt(nu/3.14159)
d1<-0.5*nu
#(2) Coefficients
for(k in 1:4){beta[k]~dnorm(0,0.01)}
for (k in 1:3){alpha[k]~dnorm(0,0.01)}
#(3) Skewness parameters
delta ~ dnorm(0, 0.01)
#(4) Precision parameters
Isigma~dgamma(0.01,0.01)
sigma<-1/Isigma
Isigma2~dgamma(0.01,0.01)
sigma2<-1/Isigma2
#(5) Variance-covariance matrix
Omega[1:4,1:4] ~ dwish(R[,],4)
V1[1:4,1:4]<-inverse(Omega[,])
Omega3[1:3,1:3] ~ dwish(R3[,],3)
V3[1:3,1:3]<-inverse(Omega3[,])
}
##End of model
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Appendix C: WinBUGS program code for Model ST in
Chapter 5
## WinBUGS program code named Chapter5-ST.txt
model
{
for (i in 1:n) #total number of subjects
{
# Latent random variables generated by ST dist.
u.e[i] ~ dgamma(d1,d1)
# Random effects of response model
b0[i,1]<-0
b0[i,2]<-0
b0[i,3]<-0
b0[i,4]<-0
b[i,1:4]~dmnorm(b0[i,1:4], Omega[,])
# Random effects of covariate model
a3[i,1]<-0
a3[i,2]<-0
a3[i,3]<-0
a[i,1:3]~dmnorm(a3[i,1:3], Omega3[,])
}
#Time to event model
for (i in 1:n) {
for(j in 1:Tnum) {
risk[i,j] <- step(obs.t[i] - t[j] + eps)
dN[i,j] <- risk[i, j] * step(t[j + 1] - obs.t[i] - eps) * fail[i]
}
}
for(j in 1:Tnum) {
for(i in 1:n) {
dN[i, j] ~ dpois(Idt[i, j])
Idt[i, j]<-risk[i, j]*exp(gamma[1]*b[i,1]+gamma[2]*a[i,2]
+gamma[3]*base[i,5]+gamma[4]*base[i,4])*dL0[j]
}
dL0[j] ~ dgamma(mucox[j], c)
mucox[j] <- dL0.star[j] * c
}
c <- 0.1
r <- 1
for (j in 1 : Tnum) { dL0.star[j] <- r * (t[j + 1] - t[j]) }
for (j in 1:N) #total number of measurements
{ #Measurement error model with ST distribution
w2[j] ~ dnorm(0, u.e[y[j,1]])I(0,)
aau2[j]<-u.e[y[j,1]]*Isigma2
z.star[j]<-(alpha[1]+a[y[j,1],1])+(alpha[2]+a[y[j,1],2])*y[j,3]
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+(alpha[3]+a[y[j,1],3])*y[j,3]*y[j,3]
z.mean[j]<- z.star[j]+delta*(w2[j]-mue2)
y[j,6] ~ dnorm(z.mean[j], aau2[j])
# y[j,1]=patid, y[,3]=time, y[j,6]=standardized cd4
# Response models with ALD dist. (tau=0.50)
para[j] <- z.mean[j]*(beta[1]+b[y[j,1],1])
npara[j] <-(beta[2]+ b[y[j,1],2])+(beta[3]+ b[y[j,1],3])*spline[j,3]
+(beta[4]+ b[y[j,1],4])*spline[j,4]
dm[j] <- para[j] + npara[j]
v.ald[j] ~ dexp(Isigma)I(1,)
mu[j]<-dm[j]+(1-2*tau)/(tau*(1-tau))*v.ald[j]
aau[j]<-(tau*(1-tau))/(2*sigma*v.ald[j])
# LOD
upper.limit[j] <-Below.detection*y[j,13]+upper.bound*(1-y[j,13])
y[j,12] ~dnorm(mu[j], aau[j])I(,upper.limit[j])
# y[j,13]=censoring indicator, y[,12]=log(viral load)
}
# Prior distributions of the hyperparameters
#(1) Degree of freedom
nu ~ dexp(0.1) I(3,)
mue2 <- exp(loggam(0.5*(nu-1.))-loggam(0.5*nu))*sqrt(nu/3.14159)
d1<-0.5*nu
#(2) Coefficients
for(k in 1:4){beta[k]~dnorm(0,0.01)}
for(k in 1:3){alpha[k]~dnorm(0,0.01)}
for(k in 1:4){gamma[k]~dnorm(0,0.01)}
#(3) Skewness parameters
delta ~ dnorm(0, 0.01)
#(4) Precision parameters
Isigma~dgamma(0.01,0.01)
sigma<-1/Isigma
Isigma2~dgamma(0.01,0.01)
sigma2<-1/Isigma2
#(5) Variance-covariance matrix
Omega[1:4,1:4] ~ dwish(R[,],4)
V1[1:4,1:4]<-inverse(Omega[,])
Omega3[1:3,1:3] ~ dwish(R3[,],3)
V3[1:3,1:3]<-inverse(Omega3[,])
}
##End of model
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